GO	[-6.85 -0.59]	[-0.59 -0.30]	[-0.30 -0.15]	[-0.15 -0.04]	[-0.04 0.00]	[0.00 0.00]	[0.00 0.13]	[0.13 0.28]	[0.28 0.55]	[0.55 1.08]	[1.08 24.36]
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	-1.755	2.247	6.509	5.587	-0.707	-4.522	1.456	-0.707	-0.543	-5.456	-6.674
FUJII_YBX1_TARGETS_DN FUJII_YBX1_TARGETS_DN	-2.167	0.797	6.671	7.125	-0.506	-6.718	1.144	0.405	-0.814	-3.561	-4.857
BENPORATH_PROLIFERATION BENPORATH_PROLIFERATION	-4.049	1.832	5.076	6.976	-1.153	-4.949	0.903	0.433	-0.528	-4.049	-3.312
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	-2.397	0.629	5.588	6.049	-0.608	-4.267	1.914	0.974	-1.960	-3.527	-5.166
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	-6.322	0.647	2.649	1.825	-1.062	-3.840	6.416	1.825	0.514	-4.525	-3.238
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	-1.784	0.736	3.539	3.895	-1.466	-6.085	2.566	2.566	-0.345	-4.315	-5.094
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	-3.761	0.403	8.173	3.097	-0.580	-4.638	2.746	0.693	-1.274	-3.761	-3.048
WINNEPENNINCKX_MELANOMA_METASTASIS_UP WINNEPENNINCKX_MELANOMA_METASTASIS_UP	-3.799	2.212	5.523	4.268	-1.162	-5.496	1.671	1.005	-2.628	-1.779	-3.151
KONDO_PROSTATE_CANCER_WITH_H3K27ME3 KONDO_PROSTATE_CANCER_WITH_H3K27ME3	3.486	-0.829	-4.203	-3.061	2.555	10.570	-3.061	-3.061	-1.028	-0.399	0.400
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	-2.464	2.731	4.054	5.615	-0.596	-4.735	1.036	1.036	-1.725	-5.559	-2.902
PUJANA_XPRSS_INT_NETWORK PUJANA_XPRSS_INT_NETWORK	-2.331	2.910	3.961	3.244	-0.486	-5.731	3.594	-0.486	-0.813	-4.779	-3.340
SCHUHMACHER_MYC_TARGETS_UP SCHUHMACHER_MYC_TARGETS_UP	-0.865	11.349	4.109	-0.865	-1.225	-3.319	0.724	-1.225	-0.596	-2.363	-2.355
HOLLERN_SQUAMOUS_BREAST_TUMOR HOLLERN_SQUAMOUS_BREAST_TUMOR	0.402	-0.689	-2.440	-4.142	2.753	8.161	-3.483	-2.440	-1.362	0.301	3.432
LEE_LIVER_CANCER_SURVIVAL_DN LEE_LIVER_CANCER_SURVIVAL_DN	-4.385	2.495	1.457	6.225	-1.830	-5.186	2.209	0.440	-1.230	-0.270	-3.117
WELCSH_BRCA1_TARGETS_DN WELCSH_BRCA1_TARGETS_DN	-0.594	4.210	2.703	4.634	-3.093	-4.677	0.676	-0.442	0.391	-3.093	-3.783
RAMALHO_STEMNESS_UP RAMALHO_STEMNESS_UP	-2.624	1.738	3.782	4.134	-0.844	-6.797	1.510	0.926	-0.408	-2.217	-3.607
WU_CELL_MIGRATION WU_CELL_MIGRATION	-1.308	-1.308	-1.308	-1.925	-1.594	0.301	-2.746	-1.308	0.301	7.343	9.392
PUJANA_BRCA_CENTERED_NETWORK PUJANA_BRCA_CENTERED_NETWORK	-1.843	5.246	1.998	3.447	-0.443	-3.790	1.695	-0.312	-1.843	-3.790	-2.971
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	-2.803	0.620	2.577	4.626	-0.701	-4.595	2.021	1.114	0.379	-1.347	-6.381
WHITFIELD_CELL_CYCLE_G2_M WHITFIELD_CELL_CYCLE_G2_M	-1.929	-0.712	3.321	2.151	-1.335	-5.896	3.321	3.006	0.583	-1.929	-3.700
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	-4.911	1.124	0.944	3.160	-0.517	-4.203	5.744	1.535	-1.028	-1.528	-3.046
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	-3.653	1.914	1.914	2.878	-0.940	-5.692	2.536	1.379	-0.539	-1.926	-2.384
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	-3.873	1.338	7.273	0.502	-0.536	-3.873	1.559	1.338	0.293	-2.333	-3.269
WANG_CLIM2_TARGETS_DN WANG_CLIM2_TARGETS_DN	-2.281	1.385	1.385	2.685	-1.044	-4.490	2.685	2.995	-1.288	-0.660	-5.279
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	-3.677	-0.354	0.577	2.530	-1.487	-5.149	2.530	1.718	3.494	-0.608	-3.661
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN	-1.997	1.992	4.197	3.836	-0.432	-5.447	1.992	-0.560	-1.114	-1.659	-2.817
DANG_MYC_TARGETS_UP DANG_MYC_TARGETS_UP	-2.734	3.209	1.583	4.885	0.282	-4.251	1.583	-1.369	-1.063	-0.610	-3.391
REN_BOUND_BY_E2F REN_BOUND_BY_E2F	-1.152	5.205	0.970	4.590	-1.712	-1.712	0.301	0.478	-1.712	-2.571	-2.564
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	-3.485	0.636	4.310	4.310	-0.672	-1.836	2.081	-0.958	-0.458	-2.510	-2.502
WHITFIELD_CELL_CYCLE_G2 WHITFIELD_CELL_CYCLE_G2	-1.301	1.055	1.055	2.870	-0.498	-7.027	3.548	1.481	-0.648	-2.833	-1.939
KONG_E2F3_TARGETS KONG_E2F3_TARGETS	-2.264	1.542	2.977	3.403	-0.678	-2.994	3.854	-0.678	-1.709	-2.264	-2.255
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	-5.183	0.367	0.791	2.199	-0.608	-5.183	4.713	1.403	0.487	-0.791	-1.949
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	-1.201	2.437	1.870	4.164	-0.957	-3.867	1.870	0.630	-0.581	-3.228	-3.852
ELVIDGE_HYPOXIA_DN ELVIDGE_HYPOXIA_DN	-2.228	2.116	2.744	3.449	-1.807	-4.049	3.087	-0.904	-0.284	-1.153	-2.716
KARLSSON_TGFB1_TARGETS_UP KARLSSON_TGFB1_TARGETS_UP	-1.558	5.370	4.892	0.486	-2.509	-3.982	0.828	-0.255	-0.255	-1.985	-1.550
UDAYAKUMAR_MED1_TARGETS_UP UDAYAKUMAR_MED1_TARGETS_UP	-0.384	0.763	1.948	2.577	-0.703	-5.650	0.763	2.923	-0.384	-2.929	-3.604
HUANG_GATA2_TARGETS_UP HUANG_GATA2_TARGETS_UP	-1.520	-1.883	-2.312	-0.424	-1.883	-4.158	1.484	0.845	4.891	4.063	0.295
WHITEFORD_PEDIATRIC_CANCER_MARKERS WHITEFORD_PEDIATRIC_CANCER_MARKERS	-2.319	0.755	2.724	5.320	-0.598	-4.858	1.730	0.301	-1.077	-1.815	-1.400
CROONQUIST_IL6_DEPRIVATION_DN CROONQUIST_IL6_DEPRIVATION_DN	-3.943	0.612	2.681	5.526	-0.301	-2.197	1.615	-0.301	-2.197	-1.650	-1.220
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	-2.473	0.657	4.390	2.523	-0.934	-3.444	1.768	0.883	-1.308	-2.473	-1.302
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	-1.095	-0.889	0.463	0.875	-2.705	-5.896	3.996	1.898	3.321	-0.562	-1.600
EPPERT_PROGENITOR EPPERT_PROGENITOR	-1.953	3.192	1.880	3.968	-0.959	-5.734	0.565	0.565	-0.959	-0.735	-1.943
KAUFFMANN_MELANOMA_RELAPSE_UP KAUFFMANN_MELANOMA_RELAPSE_UP	-0.738	4.100	2.094	2.094	-1.677	-2.529	1.325	-0.470	-0.738	-2.529	-2.522
PUJANA_BREAST_CANCER_LIT_INT_NETWORK PUJANA_BREAST_CANCER_LIT_INT_NETWORK	-1.029	2.760	1.405	5.555	-2.399	-3.145	0.687	0.359	-0.537	-3.145	-1.374
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	-1.074	1.687	4.042	2.915	-0.834	-3.904	2.261	-1.706	-0.350	-1.706	-2.594
TIEN_INTESTINE_PROBIOTICS_6HR_DN TIEN_INTESTINE_PROBIOTICS_6HR_DN	-1.976	-0.385	1.035	1.695	-1.976	-4.853	1.035	6.828	-0.510	0.318	-1.964
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	-1.877	2.078	4.856	3.688	-1.241	-1.877	0.926	0.260	-1.241	-2.277	-2.731
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	-2.256	1.510	3.207	1.246	-1.358	-4.775	2.116	0.452	0.795	-2.256	-1.751
KARLSSON_TGFB1_TARGETS_DN KARLSSON_TGFB1_TARGETS_DN	-1.278	-0.672	-1.549	0.386	-2.624	-4.236	2.521	1.983	5.277	0.926	-1.269
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	-3.107	0.371	3.223	2.813	-0.733	-4.151	0.921	1.438	0.371	-1.355	-2.356
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	-2.637	1.404	1.404	1.930	-1.731	-4.832	0.612	3.225	0.777	-2.637	-0.845
MISSIAGLIA_REGULATED_BY_METHYLATION_DN MISSIAGLIA_REGULATED_BY_METHYLATION_DN	-3.122	1.850	3.633	1.850	0.254	-3.943	2.161	-0.677	-0.496	-2.477	-1.179
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	0.392	-1.691	-1.691	-2.952	2.128	1.169	-2.952	-2.468	0.392	2.128	4.496
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	-2.192	0.944	2.275	3.160	-0.829	-4.911	1.321	0.507	1.535	-2.597	-2.179
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	-2.043	0.788	3.080	3.878	-0.538	-2.573	2.045	0.610	-1.254	-2.043	-3.215
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	2.081	-0.541	-2.759	-0.921	-3.359	0.421	-2.256	-0.921	-0.292	2.382	5.949
KAUFFMANN_DNA_REPLICATION_GENES KAUFFMANN_DNA_REPLICATION_GENES	-2.200	3.132	3.497	3.497	-0.682	-2.698	0.445	0.329	-1.133	-1.781	-2.189
RICKMAN_HEAD_AND_NECK_CANCER_E RICKMAN_HEAD_AND_NECK_CANCER_E	1.023	-1.029	-1.933	-1.420	1.943	4.590	-3.610	-1.933	-1.029	1.023	1.030
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	-0.737	2.474	1.404	5.030	-0.940	-3.833	1.404	0.284	-2.197	-1.804	-1.458
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	-0.512	-1.167	-1.487	-2.336	-0.903	-0.265	-1.167	-1.167	0.782	1.698	9.851
FISCHER_G1_S_CELL_CYCLE FISCHER_G1_S_CELL_CYCLE	-2.342	1.610	1.843	5.406	-1.130	-4.403	0.442	0.341	0.692	-1.373	-1.642
RICKMAN_HEAD_AND_NECK_CANCER_C RICKMAN_HEAD_AND_NECK_CANCER_C	0.593	-1.383	-1.383	-1.787	2.076	4.435	-2.913	-2.913	-0.418	0.439	2.425
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	-1.406	0.457	4.763	3.178	-1.113	-4.871	-0.371	1.377	-0.371	-1.756	-0.862
RUIZ_TNC_TARGETS_DN RUIZ_TNC_TARGETS_DN	-0.623	2.960	3.320	2.960	-0.817	-4.754	0.369	-0.623	-2.576	-0.465	-1.047
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	-2.946	0.436	4.008	3.000	-1.447	-2.946	0.845	1.635	-1.747	-1.747	0.338
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	-2.351	0.735	4.305	0.735	-1.432	-3.790	3.050	0.561	0.291	-1.843	-1.092
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-0.517	-2.192	-1.528	-1.260	-1.260	-3.061	-0.302	-0.302	3.486	3.486	3.506
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	-3.796	-0.442	0.676	1.051	-1.016	-5.859	1.272	0.283	3.418	-0.442	0.859
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN	-2.101	0.938	2.639	0.768	-1.424	-7.278	0.768	1.126	0.485	0.768	-1.146
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	-1.990	2.485	3.014	0.848	0.351	-1.990	1.180	-0.256	-1.225	-1.990	-1.984
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	-0.722	-3.165	-0.556	-1.162	-1.162	-3.165	0.517	1.430	0.517	1.005	6.948
ROSS_AML_WITH_MLL_FUSIONS ROSS_AML_WITH_MLL_FUSIONS	-1.707	-0.255	-0.255	-0.397	-3.319	-3.319	-0.255	0.520	4.109	3.136	-0.394
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	-3.291	1.810	3.688	2.365	-0.464	-3.936	1.330	-0.608	-0.464	-0.992	-1.232
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	-2.341	3.259	1.226	1.708	-0.436	-2.852	2.581	0.388	-0.436	-1.909	-2.839
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	-2.365	-2.365	0.954	0.954	-0.703	-4.483	2.923	1.406	1.169	0.954	-1.502
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	-1.973	1.769	3.532	1.533	0.491	-3.315	2.577	-0.882	-0.882	-1.637	-1.960
PODAR_RESPONSE_TO_ADAPHOSTIN_UP PODAR_RESPONSE_TO_ADAPHOSTIN_UP	-0.402	-1.474	-1.173	1.300	-1.832	-6.192	1.300	1.081	2.382	1.539	-0.398
CROONQUIST_NRAS_SIGNALING_DN CROONQUIST_NRAS_SIGNALING_DN	-2.903	0.737	1.636	4.412	0.342	-1.999	1.636	-0.422	-1.393	-1.999	-0.956
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	-0.293	-0.693	-0.531	-0.693	-5.417	-3.102	0.416	-0.293	1.996	2.282	3.268
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	-1.661	0.432	1.679	-0.292	-2.637	-4.136	2.623	1.971	1.679	-0.566	-1.652
DER_IFN_BETA_RESPONSE_UP DER_IFN_BETA_RESPONSE_UP	-3.220	0.849	3.053	1.340	-1.074	-4.276	1.340	0.476	0.849	-1.074	-1.068
KAMMINGA_EZH2_TARGETS KAMMINGA_EZH2_TARGETS	-1.699	0.783	3.082	1.997	0.501	-1.699	1.129	-0.318	-1.699	-1.699	-1.695
LI_DCP2_BOUND_MRNA LI_DCP2_BOUND_MRNA	-2.658	0.759	-0.751	2.263	-0.351	-3.652	1.565	2.263	0.759	-0.522	-2.649
WHITFIELD_CELL_CYCLE_G1_S WHITFIELD_CELL_CYCLE_G1_S	-3.511	0.820	1.763	3.063	-0.486	-2.831	-0.352	2.706	0.361	-1.125	-2.266
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	-1.580	0.598	2.096	3.408	-0.523	-3.153	1.387	0.265	0.265	-1.117	-3.144
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	-0.663	-0.663	-0.663	-0.663	2.696	6.742	-0.663	-0.663	-0.663	-0.663	-0.661
BROWNE_HCMV_INFECTION_6HR_DN BROWNE_HCMV_INFECTION_6HR_DN	-1.852	0.268	-0.975	0.945	-1.852	-3.901	4.914	2.708	-0.337	0.770	-0.967
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	-1.787	-0.291	0.593	4.905	0.311	-3.714	1.218	0.311	1.479	-1.787	-2.278
WHITFIELD_CELL_CYCLE_S WHITFIELD_CELL_CYCLE_S	-1.153	2.420	1.832	1.325	-1.153	-4.049	3.087	-1.153	0.568	-1.807	-1.145
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	-0.861	-0.521	-0.521	-2.892	-2.001	-0.395	-0.395	-0.861	-0.395	5.406	5.010
JIANG_HYPOXIA_NORMAL JIANG_HYPOXIA_NORMAL	-0.458	-0.919	4.629	0.559	-3.236	-5.124	-0.586	0.692	1.843	0.559	-0.261
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	0.370	1.620	4.317	0.883	-1.191	-1.948	0.883	-0.431	-1.191	-1.948	-1.943
GROSS_HYPOXIA_VIA_HIF1A_UP GROSS_HYPOXIA_VIA_HIF1A_UP	-0.541	0.798	4.904	2.046	-1.612	-3.194	1.350	-0.797	-1.144	-1.144	-0.793
VERNELL_RETINOBLASTOMA_PATHWAY_UP VERNELL_RETINOBLASTOMA_PATHWAY_UP	-1.393	1.297	0.519	6.892	-0.647	-2.903	-0.647	0.519	0.342	-1.393	-1.387
GOLDRATH_HOMEOSTATIC_PROLIFERATION GOLDRATH_HOMEOSTATIC_PROLIFERATION	-1.452	0.433	4.227	1.568	-0.697	-3.326	0.725	1.325	0.568	-1.452	-3.312
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN	1.163	-0.312	-1.843	-0.829	0.413	-0.829	-1.432	-2.351	-1.099	1.417	7.392
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	2.521	0.496	-0.844	-1.278	-3.623	-1.278	-1.278	-1.860	0.926	2.521	3.140
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	-2.382	-1.457	0.400	2.283	0.281	-4.942	2.630	1.137	0.716	0.281	-1.113
ZHANG_RESPONSE_TO_CANTHARIDIN_DN ZHANG_RESPONSE_TO_CANTHARIDIN_DN	-1.891	1.776	1.096	0.818	1.416	-2.779	1.416	0.581	-0.586	-1.891	-2.771
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	-0.442	-3.444	-0.289	-0.442	-1.803	-1.803	-0.934	-0.289	2.946	2.946	2.140
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	-0.412	-1.615	-0.867	-0.867	-1.615	-3.284	-0.867	0.502	3.928	2.613	2.630
VILLANUEVA_LIVER_CANCER_KRT19_UP VILLANUEVA_LIVER_CANCER_KRT19_UP	-1.155	0.485	1.333	5.171	-0.436	-2.101	2.064	0.617	-1.155	-2.523	-2.089
ALONSO_METASTASIS_UP ALONSO_METASTASIS_UP	-4.911	0.301	0.635	0.944	-1.260	-3.061	0.396	2.850	2.850	-0.829	0.305
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	-3.936	1.330	1.810	1.330	-0.782	-1.534	2.992	0.754	-0.608	-0.464	-3.277
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	-1.463	0.351	0.627	0.998	0.477	-4.405	5.079	0.627	-0.257	-0.671	-2.852
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	-0.651	-2.637	-0.323	0.952	-1.567	-4.484	3.185	1.191	1.458	-0.465	0.564
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 MIKKELSEN_IPS_WITH_HCP_H3K27ME3	1.945	-0.569	-1.888	-2.466	-0.398	2.289	-1.434	-0.790	-0.790	-0.569	5.410
BROCKE_APOPTOSIS_REVERSED_BY_IL6 BROCKE_APOPTOSIS_REVERSED_BY_IL6	-2.145	0.469	0.612	0.469	-2.145	-6.025	0.612	0.964	0.469	2.872	0.474
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	-2.280	2.473	2.473	2.473	-0.600	-1.466	0.637	-0.600	-0.600	-2.280	-0.945
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	-1.243	2.991	0.880	2.361	0.880	-1.243	-1.243	0.283	-1.243	-1.243	-1.240
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	-1.807	0.344	2.242	2.242	-2.606	-3.102	3.157	-0.354	0.721	-0.468	-1.477
WIERENGA_STAT5A_TARGETS_DN WIERENGA_STAT5A_TARGETS_DN	-0.506	-0.647	-0.814	-0.389	-1.241	-4.876	0.962	-1.508	1.343	2.307	3.893
ZHAN_MULTIPLE_MYELOMA_PR_UP ZHAN_MULTIPLE_MYELOMA_PR_UP	-1.158	-1.158	0.920	3.193	-0.702	-1.907	4.433	0.389	-1.158	-1.158	-0.699
SONG_TARGETS_OF_IE86_CMV_PROTEIN SONG_TARGETS_OF_IE86_CMV_PROTEIN	-0.949	2.473	0.637	4.706	-0.365	-2.280	0.637	-0.365	-1.466	-1.466	-1.461
WAKASUGI_HAVE_ZNF143_BINDING_SITES WAKASUGI_HAVE_ZNF143_BINDING_SITES	-1.431	3.602	2.076	0.664	-0.921	-2.239	0.944	0.435	-0.348	-1.431	-2.233
WELCSH_BRCA1_TARGETS_UP WELCSH_BRCA1_TARGETS_UP	-1.975	-0.586	0.842	0.559	-0.739	-3.779	2.636	5.010	0.341	-0.919	-1.120
BASSO_B_LYMPHOCYTE_NETWORK BASSO_B_LYMPHOCYTE_NETWORK	-2.172	0.597	2.498	1.150	-1.756	-4.871	1.150	0.457	1.897	-0.667	-0.862
MEISSNER_NPC_HCP_WITH_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K27ME3	0.538	-0.383	-1.675	-1.198	0.748	4.189	-3.277	-2.326	-0.244	0.538	1.604
TAVOR_CEBPA_TARGETS_UP TAVOR_CEBPA_TARGETS_UP	-2.156	-0.535	-1.362	-1.362	-1.362	-0.865	-0.535	1.364	1.761	0.476	5.065
JISON_SICKLE_CELL_DISEASE_DN JISON_SICKLE_CELL_DISEASE_DN	-2.860	-0.442	0.468	2.804	-0.914	-2.860	1.484	3.446	0.593	-0.572	-2.008
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	0.412	-0.775	-1.117	-1.580	2.501	3.908	-1.580	-3.153	-0.341	0.265	1.093
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	1.264	0.721	-0.608	-1.487	-3.102	-1.807	-0.608	-2.178	1.264	3.157	2.257
KAAB_FAILED_HEART_ATRIUM_DN KAAB_FAILED_HEART_ATRIUM_DN	-2.200	-0.381	0.923	2.786	0.329	-4.013	1.351	0.582	1.597	-0.682	-2.685
SMIRNOV_RESPONSE_TO_IR_6HR_UP SMIRNOV_RESPONSE_TO_IR_6HR_UP	-1.281	-1.926	-0.486	-0.366	-1.281	-4.004	0.574	2.594	3.961	0.574	0.729
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	-0.782	2.929	1.137	4.096	-0.472	-1.259	0.334	-0.782	-1.259	-2.031	-1.255
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	-0.869	3.665	0.576	2.114	-0.312	-2.603	0.976	0.419	-0.312	-2.603	-2.592
ABRAMSON_INTERACT_WITH_AIRE ABRAMSON_INTERACT_WITH_AIRE	-1.090	5.388	0.684	0.684	-0.650	-1.090	0.430	0.998	-1.090	-1.824	-1.819
LEE_NEURAL_CREST_STEM_CELL_DN LEE_NEURAL_CREST_STEM_CELL_DN	-0.343	0.262	-1.164	-2.445	-1.164	-0.661	-0.483	-1.508	0.679	1.595	7.120
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	-0.392	0.903	-1.452	1.103	-3.326	-4.049	-0.528	0.433	1.103	3.449	0.437
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	0.277	0.751	-0.898	-0.714	-2.831	-1.659	-1.659	-0.898	1.293	1.992	4.991
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	1.459	-0.817	-1.682	-0.623	-0.465	-1.054	-1.682	-2.089	0.495	1.998	5.423
RHODES_CANCER_META_SIGNATURE RHODES_CANCER_META_SIGNATURE	-1.783	0.906	1.205	1.928	-0.527	-2.654	2.808	0.651	-1.211	-1.783	-0.806
RICKMAN_HEAD_AND_NECK_CANCER_A RICKMAN_HEAD_AND_NECK_CANCER_A	1.309	-0.411	-1.460	-2.500	-0.585	0.827	-1.918	-0.810	-1.097	2.998	3.429
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	-0.935	-1.363	-1.363	-0.935	1.336	3.428	-1.963	-0.626	-0.626	-0.252	3.964
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	-0.242	-0.242	4.317	-0.242	-1.191	-0.729	3.102	-0.242	-1.948	-0.729	-1.943
YAGI_AML_WITH_T_9_11_TRANSLOCATION YAGI_AML_WITH_T_9_11_TRANSLOCATION	-2.218	0.273	2.452	0.273	-0.831	-4.290	-0.331	3.950	0.518	-0.831	0.388
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	2.227	-0.385	-1.976	-1.623	-0.845	-0.510	-2.863	-1.063	1.456	1.952	2.848
BURTON_ADIPOGENESIS_3 BURTON_ADIPOGENESIS_3	-1.858	0.492	3.109	1.665	0.492	-2.432	2.334	-0.260	-1.051	-1.858	-1.400
WONG_ENDMETRIUM_CANCER_DN WONG_ENDMETRIUM_CANCER_DN	0.558	-1.171	-0.820	-1.643	0.243	0.772	-0.820	-2.290	0.381	-0.369	7.282
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	-2.197	0.455	0.980	3.135	-1.397	-2.197	1.706	-0.893	0.980	-0.556	-0.888
LY_AGING_OLD_DN LY_AGING_OLD_DN	-1.501	1.190	2.405	3.993	-0.622	-0.622	-0.622	-0.622	0.397	-2.322	-1.496
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	-2.862	-0.626	1.681	1.336	-0.252	-2.862	2.484	0.539	0.539	-0.626	-1.357
TIEN_INTESTINE_PROBIOTICS_2HR_DN TIEN_INTESTINE_PROBIOTICS_2HR_DN	-2.696	-0.771	1.528	0.967	-0.538	-2.696	1.231	3.018	0.539	-0.364	-1.991
DAZARD_UV_RESPONSE_CLUSTER_G6 DAZARD_UV_RESPONSE_CLUSTER_G6	-0.834	0.482	1.431	1.197	-1.362	-3.904	2.261	1.963	-0.350	-0.478	-2.594
LAIHO_COLORECTAL_CANCER_SERRATED_UP LAIHO_COLORECTAL_CANCER_SERRATED_UP	-2.256	-0.405	-1.034	0.610	-1.358	-2.878	1.246	3.617	2.456	-0.567	-0.278
ISHIDA_E2F_TARGETS ISHIDA_E2F_TARGETS	-1.362	0.720	0.476	3.220	-0.535	-0.865	2.690	0.286	-0.535	-2.156	-2.150
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	-1.966	-0.351	3.529	1.899	-0.351	-0.751	1.899	0.557	-1.053	-1.448	-2.649
MENSE_HYPOXIA_UP MENSE_HYPOXIA_UP	-1.355	-0.733	1.164	-0.360	-1.355	-4.151	-1.006	2.813	1.740	0.707	0.712
RIGGI_EWING_SARCOMA_PROGENITOR_DN RIGGI_EWING_SARCOMA_PROGENITOR_DN	0.396	-0.829	-0.829	-0.659	-1.837	-1.837	0.396	-1.837	0.507	3.160	4.960
PECE_MAMMARY_STEM_CELL_UP PECE_MAMMARY_STEM_CELL_UP	-1.953	-1.953	0.426	1.351	-0.735	-2.425	1.351	1.351	3.192	-1.953	0.431
COLLER_MYC_TARGETS_UP COLLER_MYC_TARGETS_UP	-0.462	5.555	1.213	0.772	-0.462	-0.994	-0.204	-0.994	-0.994	-0.994	-0.991
DE_YY1_TARGETS_DN DE_YY1_TARGETS_DN	-2.845	-0.418	0.324	3.210	-1.176	-2.845	1.385	2.395	-0.279	-0.418	-0.602
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	-2.132	1.951	3.023	1.109	-0.950	-2.740	0.511	0.682	0.511	-2.132	-0.944
MORI_IMMATURE_B_LYMPHOCYTE_DN MORI_IMMATURE_B_LYMPHOCYTE_DN	-1.127	-0.258	0.693	4.279	-0.812	-0.812	3.334	0.349	-1.127	-1.534	-2.056
RICKMAN_HEAD_AND_NECK_CANCER_D RICKMAN_HEAD_AND_NECK_CANCER_D	0.898	-0.893	-0.893	-0.893	1.278	5.525	-1.575	-0.893	-0.893	-0.893	0.587
LEE_EARLY_T_LYMPHOCYTE_UP LEE_EARLY_T_LYMPHOCYTE_UP	-1.214	-0.479	1.163	3.130	-0.334	-2.671	1.715	1.426	-0.334	-2.671	-1.207
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	-0.893	-0.332	-1.397	-0.556	-2.197	-2.197	0.455	0.691	4.295	0.980	0.695
BROWNE_HCMV_INFECTION_24HR_DN BROWNE_HCMV_INFECTION_24HR_DN	0.348	0.469	-0.360	-3.226	-1.384	-2.637	-1.093	0.777	1.173	0.964	4.008
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	-0.283	-0.396	-1.926	-2.962	0.745	1.914	-1.209	-1.926	-0.283	1.914	2.893
DAZARD_RESPONSE_TO_UV_SCC_DN DAZARD_RESPONSE_TO_UV_SCC_DN	-1.760	0.452	2.116	0.610	-0.774	-3.676	3.207	1.246	-0.405	-1.034	-1.027
BROWNE_HCMV_INFECTION_18HR_UP BROWNE_HCMV_INFECTION_18HR_UP	-2.440	0.301	0.301	2.448	-1.669	-2.922	2.160	2.160	0.301	0.402	-1.352
JISON_SICKLE_CELL_DISEASE_UP JISON_SICKLE_CELL_DISEASE_UP	-1.901	-0.836	0.526	0.526	-2.281	-3.808	2.114	-0.513	2.114	0.987	1.187
RICKMAN_HEAD_AND_NECK_CANCER_B RICKMAN_HEAD_AND_NECK_CANCER_B	0.245	-0.949	-1.466	-1.466	0.245	0.245	-1.466	0.245	-0.600	0.637	7.540
SAGIV_CD24_TARGETS_DN SAGIV_CD24_TARGETS_DN	0.226	-1.124	0.409	-1.865	-1.865	-1.124	0.958	-1.124	0.409	3.898	1.325
YAGI_AML_FAB_MARKERS YAGI_AML_FAB_MARKERS	-0.528	-0.844	0.293	1.299	-2.217	-4.947	0.926	0.926	-0.310	3.444	-0.305
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	-1.355	4.119	1.740	0.707	-0.521	-1.798	0.921	0.707	-1.798	-1.006	-1.790
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	-1.393	-1.393	1.636	2.012	-0.647	-1.999	3.353	0.519	-0.264	-1.999	-0.419
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3 MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	2.153	-1.093	-1.093	-1.093	-0.274	-0.452	-2.488	-0.715	-0.452	1.739	3.641
HOELZEL_NF1_TARGETS_UP HOELZEL_NF1_TARGETS_UP	1.813	-0.580	-1.274	-1.608	-1.608	-0.767	-0.996	-1.608	1.545	3.097	2.116
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	-2.172	0.597	1.377	0.759	-1.406	-4.871	1.897	0.943	0.759	0.338	-0.862
SERVITJA_ISLET_HNF1A_TARGETS_UP SERVITJA_ISLET_HNF1A_TARGETS_UP	0.706	-0.375	-1.601	-2.833	-1.301	1.055	-1.045	-0.498	-0.648	2.261	4.315
MILI_PSEUDOPODIA_CHEMOTAXIS_UP MILI_PSEUDOPODIA_CHEMOTAXIS_UP	-1.392	-1.392	0.806	2.363	-1.005	-1.901	2.363	1.052	1.331	-1.392	-1.385
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	-3.072	0.261	1.287	2.566	-0.959	-3.072	2.275	0.261	0.901	-0.345	-1.183
MOOTHA_VOXPHOS MOOTHA_VOXPHOS	-1.420	-0.505	0.576	2.712	-1.029	-1.933	0.576	2.712	1.297	-1.933	-1.413
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	-1.271	0.604	-0.566	1.825	-0.860	-2.737	1.825	2.673	0.250	-0.566	-1.848
MEBARKI_HCC_PROGENITOR_WNT_UP MEBARKI_HCC_PROGENITOR_WNT_UP	0.278	0.473	-1.078	-1.906	-0.427	-1.078	-1.316	-1.316	0.367	2.182	6.018
RIZ_ERYTHROID_DIFFERENTIATION RIZ_ERYTHROID_DIFFERENTIATION	-2.436	0.326	3.467	0.679	-0.427	-2.436	1.176	1.477	-0.278	-0.911	-1.764
TAKAO_RESPONSE_TO_UVB_RADIATION_DN TAKAO_RESPONSE_TO_UVB_RADIATION_DN	-1.303	0.971	0.971	1.819	-0.962	-4.068	1.819	0.971	0.269	-0.962	-1.296
SMITH_TERT_TARGETS_UP SMITH_TERT_TARGETS_UP	-0.652	2.872	-0.490	0.964	-0.652	-3.940	1.656	1.404	0.469	-1.384	-1.721
MOHANKUMAR_HOXA1_TARGETS_DN MOHANKUMAR_HOXA1_TARGETS_DN	0.660	-1.100	-1.669	-2.440	0.660	0.818	-1.362	-1.362	-0.405	3.413	2.770
IRITANI_MAD1_TARGETS_DN IRITANI_MAD1_TARGETS_DN	-1.158	1.677	1.677	1.677	-0.228	-1.907	1.271	-0.228	-1.158	-1.158	-1.901
BOUDOUKHA_BOUND_BY_IGF2BP2 BOUDOUKHA_BOUND_BY_IGF2BP2	-2.568	-0.849	0.783	1.249	0.301	-3.334	-0.301	1.249	3.297	-0.301	-1.137
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	0.987	-0.836	-0.392	-0.513	-1.901	-2.281	-1.044	-1.044	1.177	5.186	1.187
MALONEY_RESPONSE_TO_17AAG_DN MALONEY_RESPONSE_TO_17AAG_DN	-3.194	0.253	1.680	0.798	1.055	-3.194	1.350	0.578	-0.541	0.253	-1.139
BOYLAN_MULTIPLE_MYELOMA_D_DN BOYLAN_MULTIPLE_MYELOMA_D_DN	0.339	-1.253	-0.412	-0.266	-2.400	-2.400	1.209	-1.253	4.031	0.937	0.706
BURTON_ADIPOGENESIS_6 BURTON_ADIPOGENESIS_6	-0.814	1.343	-0.294	0.309	-2.571	-4.170	1.792	1.559	1.792	-1.011	-0.290
HUPER_BREAST_BASAL_VS_LUMINAL_UP HUPER_BREAST_BASAL_VS_LUMINAL_UP	0.272	-0.893	-1.397	-2.197	0.272	3.135	-1.397	-1.397	0.455	1.706	1.325
HUPER_BREAST_BASAL_VS_LUMINAL_DN HUPER_BREAST_BASAL_VS_LUMINAL_DN	0.362	-0.668	-1.035	-1.035	-0.416	-0.247	-1.571	-0.247	-1.035	0.564	7.846
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	-0.412	2.635	3.071	0.339	-1.253	-3.360	0.701	-0.412	-0.412	-1.739	-0.264
JIANG_VHL_TARGETS JIANG_VHL_TARGETS	-0.711	-0.711	1.052	2.768	0.419	-3.568	0.278	1.988	-1.005	0.419	-1.893
MUELLER_METHYLATED_IN_GLIOBLASTOMA MUELLER_METHYLATED_IN_GLIOBLASTOMA	-1.782	-0.624	-1.057	-1.057	0.254	0.715	-0.624	-1.057	0.453	0.453	6.314
SEIDEN_ONCOGENESIS_BY_MET SEIDEN_ONCOGENESIS_BY_MET	-1.477	0.539	1.528	1.856	-0.771	-2.696	3.018	0.246	0.376	-1.477	-1.470
ELVIDGE_HIF1A_TARGETS_UP ELVIDGE_HIF1A_TARGETS_UP	-1.332	0.560	2.119	2.119	-0.606	-2.820	1.728	-0.910	0.560	-0.910	-1.326
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	-1.477	1.231	3.018	2.214	0.246	-1.077	1.231	-0.771	-1.077	-1.477	-1.991
LI_CISPLATIN_RESISTANCE_DN LI_CISPLATIN_RESISTANCE_DN	1.130	-1.367	-1.367	-0.733	-1.367	0.231	-0.733	-0.733	0.231	2.092	3.315
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	-0.668	1.592	1.961	-0.276	-2.035	-2.035	1.592	1.592	-0.276	-0.986	-2.028
KANG_DOXORUBICIN_RESISTANCE_UP KANG_DOXORUBICIN_RESISTANCE_UP	-2.239	1.274	0.944	2.076	0.258	-1.431	2.076	0.258	-0.921	-1.431	-1.426
RODRIGUES_DCC_TARGETS_DN RODRIGUES_DCC_TARGETS_DN	-0.866	-1.142	0.697	0.530	-1.900	-3.867	0.530	3.338	1.111	0.891	-0.640
MAYBURD_RESPONSE_TO_L663536_DN MAYBURD_RESPONSE_TO_L663536_DN	-2.280	0.245	2.473	1.232	-0.600	-1.466	2.473	0.637	-0.949	-0.600	-1.461
JAIN_NFKB_SIGNALING JAIN_NFKB_SIGNALING	-0.314	1.815	0.288	1.815	-0.732	-3.070	1.466	0.878	-0.314	-2.144	-1.511
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	0.612	-2.145	-0.490	-0.851	-0.851	-1.731	-1.731	-0.258	3.225	1.173	2.888
DURAND_STROMA_NS_UP DURAND_STROMA_NS_UP	-0.261	-0.475	0.907	-0.475	-3.323	-1.556	-1.901	0.345	-0.261	2.951	2.968
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	0.342	3.353	0.997	-0.264	0.342	-0.961	2.012	-0.961	-0.961	-2.903	-1.387
BROWNE_HCMV_INFECTION_14HR_UP BROWNE_HCMV_INFECTION_14HR_UP	-1.048	1.352	0.599	1.591	-0.823	-3.595	1.851	1.851	-0.823	-2.012	-0.477
KERLEY_RESPONSE_TO_CISPLATIN_UP KERLEY_RESPONSE_TO_CISPLATIN_UP	-0.676	-0.676	-1.124	-1.865	-1.865	-0.676	-0.392	1.320	2.204	2.204	0.963
UEDA_CENTRAL_CLOCK UEDA_CENTRAL_CLOCK	-3.735	0.940	-0.792	0.362	-2.032	-1.102	2.959	0.521	0.714	-0.377	0.947
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	-1.077	1.088	-1.077	0.371	-1.077	-1.077	0.684	-0.241	4.290	-1.077	-0.239
AMIT_EGF_RESPONSE_480_HELA AMIT_EGF_RESPONSE_480_HELA	-0.957	0.374	1.870	0.276	-0.441	-6.818	0.276	0.276	0.630	1.379	0.379
MACAEVA_PBMC_RESPONSE_TO_IR MACAEVA_PBMC_RESPONSE_TO_IR	-0.585	-0.810	-1.460	-0.280	-0.810	-3.258	1.309	2.244	2.244	1.309	-1.091
ROSS_LEUKEMIA_WITH_MLL_FUSIONS ROSS_LEUKEMIA_WITH_MLL_FUSIONS	-1.707	0.353	1.243	-0.397	-1.707	-3.319	0.353	0.965	1.555	1.902	-0.860
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP	1.259	-0.438	-1.424	-0.986	-2.945	-1.424	2.366	1.592	-0.668	0.499	0.972
MIKKELSEN_IPS_ICP_WITH_H3K27ME3 MIKKELSEN_IPS_ICP_WITH_H3K27ME3	1.232	0.416	-0.365	-2.280	0.637	0.637	-2.280	-0.949	-0.365	-0.949	3.524
GOLDRATH_IMMUNE_MEMORY GOLDRATH_IMMUNE_MEMORY	-1.783	0.651	-0.810	-0.329	-1.783	-1.783	-0.527	0.906	2.808	2.808	-0.524
STEIN_ESRRA_TARGETS_DN STEIN_ESRRA_TARGETS_DN	-2.568	-0.438	0.783	1.249	-1.143	-3.334	2.892	0.593	1.002	-0.301	-0.613
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	-1.053	-0.351	-0.751	-3.652	-1.448	-0.751	0.995	0.995	2.263	1.899	0.393
RAMASWAMY_METASTASIS_UP RAMASWAMY_METASTASIS_UP	-0.860	1.458	1.458	0.405	0.250	-2.737	2.231	0.846	-0.860	-1.855	-1.266
EGUCHI_CELL_CYCLE_RB1_TARGETS EGUCHI_CELL_CYCLE_RB1_TARGETS	-0.911	0.217	1.356	5.057	0.217	-0.911	0.217	-0.911	-0.406	-0.911	-0.909
VANTVEER_BREAST_CANCER_METASTASIS_DN VANTVEER_BREAST_CANCER_METASTASIS_DN	-0.909	0.392	1.426	4.442	-1.595	-1.595	0.542	0.542	0.392	-2.671	-0.663
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	-1.583	0.551	0.551	2.140	-1.583	-2.455	2.454	1.575	0.301	-0.751	-1.574
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	-0.849	1.271	0.504	1.271	-1.792	-3.475	1.271	1.522	0.660	-0.342	-2.236
BURTON_ADIPOGENESIS_9 BURTON_ADIPOGENESIS_9	-1.336	0.636	-1.836	-0.672	-2.510	-1.836	0.636	0.856	1.402	1.112	2.092
WHITFIELD_CELL_CYCLE_M_G1 WHITFIELD_CELL_CYCLE_M_G1	-1.254	0.990	0.788	1.470	-0.538	-4.059	1.470	0.788	0.990	-1.254	-1.601
KIM_ALL_DISORDERS_DURATION_CORR_DN KIM_ALL_DISORDERS_DURATION_CORR_DN	-0.360	0.469	0.469	-0.490	-0.652	-3.940	1.930	2.538	1.404	-1.093	-1.721
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	-0.354	-0.354	-0.776	-0.776	-1.807	-4.350	0.577	0.451	1.718	1.065	2.853
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53 AMUNDSON_DNA_DAMAGE_RESPONSE_TP53	-0.663	-0.247	-0.663	-0.663	-0.663	-0.663	-0.663	0.762	4.517	1.292	-0.661
RUIZ_TNC_TARGETS_UP RUIZ_TNC_TARGETS_UP	-0.260	-0.482	-1.636	-0.823	-1.636	-3.595	0.934	0.463	2.130	1.352	1.863
BROWN_MYELOID_CELL_DEVELOPMENT_DN BROWN_MYELOID_CELL_DEVELOPMENT_DN	0.578	1.410	4.626	0.749	-1.299	-2.101	0.578	-1.299	-1.003	-0.412	-1.292
GALE_APL_WITH_FLT3_MUTATED_UP GALE_APL_WITH_FLT3_MUTATED_UP	-1.064	0.784	2.676	0.784	-0.691	-2.446	1.411	-0.260	-0.260	-0.260	-2.440
BURTON_ADIPOGENESIS_5 BURTON_ADIPOGENESIS_5	-2.351	1.695	1.695	1.417	0.413	-2.351	0.735	0.413	0.413	-1.099	-2.340
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR	-0.278	-0.633	0.679	-2.436	-0.911	-3.402	1.176	1.176	1.812	0.909	-0.424
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	1.741	2.542	-0.560	-1.114	-3.345	-2.385	-0.560	-0.432	1.293	0.606	0.759
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	0.768	3.415	-0.400	0.594	-0.983	-4.097	-0.282	-0.282	0.594	0.768	-2.062
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	-1.650	0.441	1.052	0.301	-0.897	-3.943	1.942	0.816	1.615	-0.447	-0.891
COLDREN_GEFITINIB_RESISTANCE_UP COLDREN_GEFITINIB_RESISTANCE_UP	-1.392	3.203	0.278	0.278	-1.005	-2.584	1.052	1.052	1.331	-1.005	-1.385
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	0.321	-0.744	-0.983	-2.605	-0.282	1.440	-0.983	-2.072	0.445	2.668	2.340
JI_RESPONSE_TO_FSH_DN JI_RESPONSE_TO_FSH_DN	-1.397	-1.397	3.135	0.980	0.691	-2.197	-0.332	1.706	-0.893	-0.556	-0.330
GENTILE_UV_RESPONSE_CLUSTER_D4 GENTILE_UV_RESPONSE_CLUSTER_D4	-1.431	0.258	-0.348	0.664	-0.921	-2.239	3.602	1.652	0.664	-0.921	-0.916
LAIHO_COLORECTAL_CANCER_SERRATED_DN LAIHO_COLORECTAL_CANCER_SERRATED_DN	-0.489	0.806	2.363	0.806	0.278	-3.568	0.419	1.644	-0.711	-1.392	-1.385
CHANDRAN_METASTASIS_TOP50_UP CHANDRAN_METASTASIS_TOP50_UP	-1.616	0.858	1.226	0.320	-0.283	-1.616	0.858	2.688	-0.925	-0.525	-1.612
KIM_GLIS2_TARGETS_UP KIM_GLIS2_TARGETS_UP	-0.301	0.301	-0.672	-3.485	-0.672	-0.958	-0.958	0.451	0.451	3.332	2.092
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	1.851	0.347	-0.482	-2.012	-2.976	-0.823	-0.636	-0.358	-0.482	2.130	2.761
FRIDMAN_SENESCENCE_UP FRIDMAN_SENESCENCE_UP	-2.253	-1.144	-0.355	-0.355	-2.253	-0.797	0.396	0.253	2.875	0.798	2.455
HOOI_ST7_TARGETS_DN HOOI_ST7_TARGETS_DN	-1.142	-0.469	0.388	-2.414	-1.482	-1.142	-0.469	0.388	0.697	1.923	4.197
GALLUZZI_PERMEABILIZE_MITOCHONDRIA GALLUZZI_PERMEABILIZE_MITOCHONDRIA	-0.599	1.477	-0.336	0.749	-1.024	-1.024	1.477	2.432	-1.741	-1.741	-0.334
GEORGES_CELL_CYCLE_MIR192_TARGETS GEORGES_CELL_CYCLE_MIR192_TARGETS	-2.571	1.284	1.284	1.640	-0.762	-1.712	0.478	1.284	-0.301	-0.489	-1.706
IKEDA_MIR30_TARGETS_UP IKEDA_MIR30_TARGETS_UP	-1.383	0.593	0.983	2.076	-0.418	-4.817	0.775	0.775	0.439	-0.418	-1.049
AIGNER_ZEB1_TARGETS AIGNER_ZEB1_TARGETS	0.680	-0.796	-0.796	-1.450	-0.796	1.030	-0.796	-1.450	-0.219	1.030	3.751
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	-0.574	3.082	0.783	2.514	-0.574	-0.574	-0.574	0.285	-1.699	-0.574	-1.695
IKEDA_MIR133_TARGETS_UP IKEDA_MIR133_TARGETS_UP	-0.650	0.239	0.430	0.998	0.998	-1.824	2.807	0.239	0.239	-1.824	-1.819
DER_IFN_GAMMA_RESPONSE_UP DER_IFN_GAMMA_RESPONSE_UP	-2.945	-0.276	1.592	-0.276	-0.668	-2.945	0.499	0.966	1.592	0.499	-0.435
ODONNELL_TFRC_TARGETS_DN ODONNELL_TFRC_TARGETS_DN	-0.442	-0.784	3.805	1.272	-1.016	-1.016	1.051	1.051	-1.016	-3.093	-0.317
CERVERA_SDHB_TARGETS_1_UP CERVERA_SDHB_TARGETS_1_UP	1.300	-0.677	-1.957	-1.533	0.254	-1.533	-0.496	-1.186	0.849	3.232	1.861
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	-0.746	-0.746	0.304	0.304	-0.746	-0.746	-0.298	-0.746	4.058	1.713	-0.744
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	-1.843	2.326	-0.312	-1.432	0.413	-2.982	0.291	0.561	3.050	-0.613	0.294
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	0.578	-0.797	-0.541	-1.612	0.253	-2.253	-0.541	-1.144	0.578	2.444	3.351
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	0.324	-1.160	-1.160	-0.580	-0.580	-0.580	-0.280	-1.160	0.324	1.962	3.981
MORI_MATURE_B_LYMPHOCYTE_DN MORI_MATURE_B_LYMPHOCYTE_DN	-0.506	-2.180	0.276	1.426	0.620	-1.549	1.769	1.769	0.620	-2.180	-1.085
RICKMAN_HEAD_AND_NECK_CANCER_F RICKMAN_HEAD_AND_NECK_CANCER_F	1.551	-1.501	-0.622	-0.977	0.877	0.612	-1.501	-0.382	-2.322	1.551	1.558
REICHERT_MITOSIS_LIN9_TARGETS REICHERT_MITOSIS_LIN9_TARGETS	-1.119	-1.119	2.052	0.347	-0.260	-1.119	1.032	1.503	0.644	-1.119	-1.116
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	-0.228	-0.228	-0.411	-1.158	-1.907	-1.158	-1.158	-0.411	0.920	2.134	3.204
HOLLERN_EMT_BREAST_TUMOR_UP HOLLERN_EMT_BREAST_TUMOR_UP	-0.580	0.291	-0.767	-1.608	-2.007	-1.274	-0.430	1.298	0.693	5.140	0.407
NGUYEN_NOTCH1_TARGETS_DN NGUYEN_NOTCH1_TARGETS_DN	-0.934	2.130	0.657	0.883	-0.934	-3.444	-0.652	1.144	1.439	-0.934	-0.648
PECE_MAMMARY_STEM_CELL_DN PECE_MAMMARY_STEM_CELL_DN	-1.384	-0.490	0.348	0.964	-1.093	-3.226	3.597	1.930	-0.490	-0.490	-0.255
DER_IFN_ALPHA_RESPONSE_UP DER_IFN_ALPHA_RESPONSE_UP	-2.144	0.642	1.815	0.445	-1.064	-3.070	0.288	1.153	1.466	-0.314	-0.727
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	0.361	-0.867	-2.831	-1.439	-0.486	0.255	-0.486	-0.486	0.255	3.063	3.458
CHOW_RASSF1_TARGETS_DN CHOW_RASSF1_TARGETS_DN	-1.243	-0.640	1.796	0.539	-0.320	-1.243	1.796	0.283	1.301	-1.243	-1.240
XIE_LT_HSC_S1PR3_OE_UP XIE_LT_HSC_S1PR3_OE_UP	-0.300	-0.610	-1.202	0.572	-1.202	-0.610	-1.202	-0.300	-0.300	3.110	2.467
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT	0.256	-0.751	-1.966	-1.053	0.759	-0.522	-1.053	-0.751	-0.351	1.565	5.058
JOHNSTONE_PARVB_TARGETS_2_UP JOHNSTONE_PARVB_TARGETS_2_UP	-1.093	-0.652	-0.258	0.469	-2.145	-3.940	0.612	1.656	1.173	1.656	0.474
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	0.679	-1.508	-1.164	-0.483	-0.885	-0.483	-0.885	-0.343	-0.483	0.870	6.575
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	-0.771	0.736	2.214	1.856	0.539	-1.999	0.736	-0.771	0.539	-1.999	-1.991
DAZARD_RESPONSE_TO_UV_SCC_UP DAZARD_RESPONSE_TO_UV_SCC_UP	-0.829	0.611	1.027	0.447	0.447	-1.949	1.279	2.559	-0.424	-1.120	-3.285
BARIS_THYROID_CANCER_DN BARIS_THYROID_CANCER_DN	-2.446	-0.691	0.784	0.346	0.541	-2.446	1.075	2.676	0.346	-0.434	-0.687
CHUNG_BLISTER_CYTOTOXICITY_UP CHUNG_BLISTER_CYTOTOXICITY_UP	-0.940	0.320	1.144	2.536	-0.940	-2.962	1.144	0.438	1.379	-1.535	-1.201
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	-0.796	1.030	-0.796	-0.796	-0.219	-1.450	1.933	-1.450	3.081	-0.219	-0.428
HOSHIDA_LIVER_CANCER_SUBCLASS_S2 HOSHIDA_LIVER_CANCER_SUBCLASS_S2	-1.383	1.765	-1.055	1.479	0.593	-2.913	2.412	0.311	0.311	-1.383	-0.577
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	-1.594	-0.674	0.301	-0.525	-1.308	-3.840	0.514	1.156	2.083	1.156	1.372
BYSTROEM_CORRELATED_WITH_IL5_DN BYSTROEM_CORRELATED_WITH_IL5_DN	-1.035	-0.416	2.747	-0.247	-0.416	-2.405	0.362	2.747	0.362	-0.416	-1.566
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	-1.999	-0.422	0.737	1.636	-0.422	-2.903	1.636	1.297	0.519	-0.961	-0.643
SWEET_KRAS_TARGETS_UP SWEET_KRAS_TARGETS_UP	-0.289	0.467	-1.803	-1.308	-1.803	-1.803	0.657	-0.289	0.657	2.523	2.140
MIKKELSEN_IPS_LCP_WITH_H3K4ME3 MIKKELSEN_IPS_LCP_WITH_H3K4ME3	2.128	-0.893	-0.893	-2.952	-0.310	-0.893	0.292	-1.118	0.292	1.169	3.388
WARTERS_RESPONSE_TO_IR_SKIN WARTERS_RESPONSE_TO_IR_SKIN	-0.278	-0.427	-1.280	-0.911	-1.280	-1.771	-0.633	0.484	5.014	0.909	0.915
BASSO_CD40_SIGNALING_DN BASSO_CD40_SIGNALING_DN	-0.438	0.328	-1.424	0.328	-2.035	-2.035	-0.668	0.328	0.966	0.966	3.800
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	-2.009	-0.451	0.290	0.576	-0.869	-3.372	1.789	1.220	1.789	0.576	-0.863
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	2.444	-1.612	-0.541	-1.612	-0.797	0.798	-1.144	-1.612	1.055	0.798	1.689
LENAOUR_DENDRITIC_CELL_MATURATION_DN LENAOUR_DENDRITIC_CELL_MATURATION_DN	-0.625	-0.625	-0.461	1.830	-2.766	-3.439	0.518	0.518	1.298	1.298	0.523
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	-1.918	-0.810	0.827	1.905	-0.810	-3.258	2.244	0.323	0.461	-0.585	0.634
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	-0.752	-0.581	-0.328	0.276	-2.224	-3.228	-0.441	0.787	1.379	3.076	0.973
WINTER_HYPOXIA_UP WINTER_HYPOXIA_UP	-1.201	2.346	2.346	1.080	-1.621	-2.164	0.840	-0.432	-0.432	-1.201	-0.287
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	-0.610	2.168	-0.448	-1.063	-0.321	-4.251	0.533	0.695	2.494	-0.610	-0.318
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	-1.064	0.541	2.676	1.411	0.346	-2.446	0.541	0.784	-1.064	-1.064	-1.059
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	-1.383	-0.792	-0.582	-0.792	-1.787	-2.288	1.765	0.775	1.479	1.765	0.990
SANA_RESPONSE_TO_IFNG_DN SANA_RESPONSE_TO_IFNG_DN	-1.933	1.023	1.604	1.604	-1.029	-1.933	0.267	0.267	-0.338	1.604	-1.926
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	0.480	-0.594	-1.512	-1.512	0.268	-0.975	-1.221	-0.975	1.140	2.401	3.395
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING LOPEZ_TRANSLATION_VIA_FN1_SIGNALING	-1.450	-0.796	1.030	0.680	-0.219	-1.450	0.680	-0.430	3.081	-0.219	-1.446
TOOKER_GEMCITABINE_RESISTANCE_UP TOOKER_GEMCITABINE_RESISTANCE_UP	-2.363	0.520	3.136	0.520	-1.225	-2.363	0.965	0.965	-0.397	-0.397	-0.394
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	-1.024	0.749	1.083	0.749	-0.599	-1.741	2.432	-0.336	0.749	-1.024	-1.736
HOLLERN_EMT_BREAST_TUMOR_DN HOLLERN_EMT_BREAST_TUMOR_DN	1.328	-0.343	-0.885	-2.445	0.679	-0.661	-0.885	-1.508	-0.483	1.595	3.301
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	0.560	-0.606	-0.240	-0.910	-0.910	-1.927	-0.390	-1.927	1.728	1.062	3.020
ONDER_CDH1_TARGETS_3_DN ONDER_CDH1_TARGETS_3_DN	-0.434	-1.606	-0.691	-0.691	0.346	2.676	-1.606	-0.691	-0.260	-0.260	3.729
CHOI_ATL_STAGE_PREDICTOR CHOI_ATL_STAGE_PREDICTOR	-1.090	0.684	0.430	-1.090	0.430	-1.824	2.807	0.998	-0.373	0.430	-1.819
JIANG_AGING_HYPOTHALAMUS_UP JIANG_AGING_HYPOTHALAMUS_UP	-2.031	0.814	-0.472	1.137	-2.031	-0.782	0.546	0.814	2.411	-0.782	-0.469
FURUKAWA_DUSP6_TARGETS_PCI35_DN FURUKAWA_DUSP6_TARGETS_PCI35_DN	-1.455	0.481	3.208	1.223	-1.012	-2.071	1.549	0.314	-1.012	-0.689	-0.451
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION NOUSHMEHR_GBM_SILENCED_BY_METHYLATION	-1.294	-0.810	-1.294	-2.073	-0.810	0.781	-0.285	0.317	1.461	1.095	2.348
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	-2.385	-1.367	2.842	0.751	0.606	-2.385	0.914	1.094	0.606	-0.898	-0.554
ZHU_CMV_ALL_UP ZHU_CMV_ALL_UP	-0.634	-0.312	0.976	0.290	-0.451	-2.603	1.491	1.789	1.491	-2.603	-0.863
IVANOVSKA_MIR106B_TARGETS IVANOVSKA_MIR106B_TARGETS	-2.658	0.256	0.256	0.995	-0.751	-2.658	0.995	0.557	2.656	0.390	-0.746
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	0.736	-0.595	-0.959	-1.192	-1.784	-0.761	-1.192	-0.458	1.085	1.746	3.916
PARK_APL_PATHOGENESIS_DN PARK_APL_PATHOGENESIS_DN	-0.755	-0.451	-0.256	-1.990	-0.755	-1.990	2.001	-0.256	0.571	2.001	0.852
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	-1.136	-1.714	0.284	1.148	-0.909	-3.548	0.284	1.832	1.585	0.957	0.386
INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP	-0.580	0.434	3.053	-0.580	-0.199	-0.580	2.211	-0.580	-0.580	-0.580	-0.578
GROSS_HYPOXIA_VIA_HIF1A_DN GROSS_HYPOXIA_VIA_HIF1A_DN	-2.705	-0.346	0.380	-1.237	-1.237	-1.237	0.905	1.991	0.380	0.261	2.704
MMS_MOUSE_LYMPH_HIGH_4HRS_UP MMS_MOUSE_LYMPH_HIGH_4HRS_UP	-1.492	0.380	0.984	-0.453	-0.234	-1.492	0.984	-0.234	2.977	-0.453	-1.488
LE_EGR2_TARGETS_UP LE_EGR2_TARGETS_UP	-0.685	0.526	2.328	2.690	-0.930	-2.101	1.136	-0.930	0.261	-1.622	-0.489
RODWELL_AGING_KIDNEY_DN RODWELL_AGING_KIDNEY_DN	0.319	0.319	1.832	-0.392	-0.697	-4.949	0.903	-0.392	1.325	-1.153	0.731
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	-1.364	-0.313	1.082	0.289	-0.691	-3.527	0.289	0.435	3.267	-0.473	0.438
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	0.389	-0.702	-0.702	-0.411	-0.411	-1.907	-1.158	0.625	-0.228	0.389	5.130
OKUMURA_INFLAMMATORY_RESPONSE_LPS OKUMURA_INFLAMMATORY_RESPONSE_LPS	0.326	-0.373	-0.373	0.849	-3.742	-1.529	0.429	0.429	4.119	0.326	-0.628
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	-0.329	-0.329	-0.329	-1.783	-0.329	-0.329	-2.654	1.205	-0.527	0.906	3.315
GAVIN_FOXP3_TARGETS_CLUSTER_T4 GAVIN_FOXP3_TARGETS_CLUSTER_T4	-1.709	0.279	2.204	-0.324	-1.709	-2.264	0.997	1.255	1.255	0.279	-0.934
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	1.791	-0.691	-1.606	-1.606	-0.434	-1.606	-0.434	1.075	-0.260	0.541	2.686
RHODES_UNDIFFERENTIATED_CANCER RHODES_UNDIFFERENTIATED_CANCER	-0.935	1.336	0.357	3.950	-0.406	-1.963	0.357	0.763	-0.626	-1.363	-0.930
CHEN_HOXA5_TARGETS_9HR_DN CHEN_HOXA5_TARGETS_9HR_DN	-1.741	0.476	1.928	1.477	-1.741	-1.024	0.749	-0.599	0.476	-1.024	0.479
HU_ANGIOGENESIS_DN HU_ANGIOGENESIS_DN	-1.533	-0.477	2.304	1.332	0.359	-1.533	0.359	-0.477	0.940	-1.533	-0.248
WINTER_HYPOXIA_DN WINTER_HYPOXIA_DN	0.750	-1.328	-2.114	-0.301	-1.328	-1.328	1.055	-0.301	1.818	1.055	0.754
GAVIN_FOXP3_TARGETS_CLUSTER_T7 GAVIN_FOXP3_TARGETS_CLUSTER_T7	-2.399	-0.250	1.405	1.136	-0.537	-1.381	0.896	0.687	2.028	-1.381	-1.374
SASAKI_ADULT_T_CELL_LEUKEMIA SASAKI_ADULT_T_CELL_LEUKEMIA	-1.578	0.722	1.507	1.282	-0.269	-4.779	0.574	0.574	0.336	0.445	-1.019
BOYLAN_MULTIPLE_MYELOMA_C_D_UP BOYLAN_MULTIPLE_MYELOMA_C_D_UP	0.710	2.454	0.710	0.551	-2.455	-3.027	0.710	0.551	0.414	-0.566	-1.244
WONG_PROTEASOME_GENE_MODULE WONG_PROTEASOME_GENE_MODULE	-1.294	-0.492	1.095	2.339	-0.810	-1.294	1.877	1.095	-0.492	-0.810	-1.289
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	-0.556	1.706	0.455	-0.332	-2.197	-2.197	1.319	-0.893	1.319	0.272	0.274
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	0.772	-0.204	-0.204	-0.994	-0.994	-0.462	-0.994	-0.994	-0.204	0.772	3.822
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	0.594	0.445	-0.983	-2.605	-2.072	0.445	-0.552	-0.552	0.445	1.191	3.432
ELVIDGE_HYPOXIA_UP ELVIDGE_HYPOXIA_UP	0.534	-1.341	1.213	-1.646	-1.341	-2.413	-0.521	0.534	0.534	2.193	1.679
VALK_AML_CLUSTER_11 VALK_AML_CLUSTER_11	-0.893	0.584	-0.500	-0.266	-1.575	-1.575	0.339	-0.893	2.222	0.339	2.230
CROMER_TUMORIGENESIS_DN CROMER_TUMORIGENESIS_DN	-0.472	-1.259	-0.472	-0.271	2.929	-0.271	-2.031	-0.271	-1.259	1.137	1.519
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	-1.367	0.606	0.606	0.751	-1.367	-4.630	1.508	-0.432	0.914	0.479	0.759
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	-1.534	0.349	0.504	-0.391	-0.572	-2.065	-0.391	-1.534	0.693	1.168	3.809
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	-2.144	0.288	1.153	2.619	-0.314	-1.517	1.153	0.642	0.288	-1.064	-1.511
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP	0.256	-0.828	-0.828	-0.351	-0.828	-0.351	-0.351	-0.828	0.256	0.991	4.567
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	-0.574	0.452	0.706	0.859	-0.725	-3.748	2.969	0.452	0.859	-0.574	-1.621
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	-0.468	-0.935	0.547	-0.598	-1.998	-3.265	2.895	0.826	0.991	0.678	0.437
LIN_NPAS4_TARGETS_UP LIN_NPAS4_TARGETS_UP	-0.845	1.236	0.547	1.695	-2.386	-3.419	0.318	1.456	0.547	-0.285	-0.504
LEE_NEURAL_CREST_STEM_CELL_UP LEE_NEURAL_CREST_STEM_CELL_UP	0.582	-0.275	-1.781	-1.781	0.742	-0.515	-1.781	-0.682	0.445	1.351	3.516
TOMLINS_PROSTATE_CANCER_UP TOMLINS_PROSTATE_CANCER_UP	-1.658	-0.549	0.820	-0.300	0.527	-1.658	-0.549	2.069	2.069	-0.300	-0.954
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	0.342	-0.943	-1.231	-1.584	-0.710	0.808	-1.231	-0.710	0.627	1.500	3.954
OUILLETTE_CLL_13Q14_DELETION_UP OUILLETTE_CLL_13Q14_DELETION_UP	-1.117	0.265	0.824	3.908	-0.341	-1.580	-0.523	0.265	-0.341	1.087	-2.209
SESTO_RESPONSE_TO_UV_C0 SESTO_RESPONSE_TO_UV_C0	-2.071	-0.668	0.392	2.373	-1.214	-1.214	0.928	2.373	0.721	-0.909	-0.663
NAKAJIMA_MAST_CELL NAKAJIMA_MAST_CELL	0.625	0.389	-0.702	-0.411	-0.702	-0.702	-1.158	-1.907	-0.228	1.271	3.803
VANTVEER_BREAST_CANCER_ESR1_UP VANTVEER_BREAST_CANCER_ESR1_UP	-0.515	0.329	-0.886	1.351	-1.133	-4.013	2.459	0.329	0.582	0.923	-0.510
SWEET_KRAS_ONCOGENIC_SIGNATURE SWEET_KRAS_ONCOGENIC_SIGNATURE	-1.448	-1.053	0.759	-0.351	-1.966	-1.966	1.264	-0.351	1.264	1.899	0.764
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	-0.373	1.025	-0.491	-0.491	-1.249	-3.742	-1.010	0.551	0.849	0.849	2.777
ZHU_CMV_24_HR_UP ZHU_CMV_24_HR_UP	-0.911	-0.278	1.176	0.484	-0.911	-1.771	2.179	1.812	0.326	-2.436	-0.424
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	-1.091	0.620	0.276	-0.506	-1.549	-2.180	-0.327	1.769	3.480	-0.327	-0.325
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN	-0.414	0.211	-0.414	-0.414	-0.414	5.322	-0.414	-0.414	-0.414	0.640	-0.413
DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	1.759	0.318	-0.518	-2.541	-1.105	2.951	-1.381	-1.105	0.557	0.318	0.884
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	-0.373	0.896	2.028	0.507	-0.537	-3.145	0.896	1.405	-0.373	-1.381	-1.374
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	-1.497	1.059	-0.301	0.864	-1.497	-2.790	2.344	0.864	0.540	0.540	-1.185
AMIT_EGF_RESPONSE_60_HELA AMIT_EGF_RESPONSE_60_HELA	-1.948	0.370	0.597	0.597	-1.948	-1.948	0.597	-0.242	0.370	0.883	1.230
ZHANG_BREAST_CANCER_PROGENITORS_DN ZHANG_BREAST_CANCER_PROGENITORS_DN	-2.962	-0.719	0.745	0.438	-0.940	-2.395	1.379	0.438	2.214	0.438	0.443
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	-0.321	0.695	1.325	0.695	-1.063	-1.369	0.881	0.881	1.325	-1.369	-3.391
BENPORATH_NOS_TARGETS BENPORATH_NOS_TARGETS	-0.270	0.564	1.690	-0.270	-0.993	-4.385	2.797	-0.479	-0.479	-0.270	-0.266
CERVERA_SDHB_TARGETS_2 CERVERA_SDHB_TARGETS_2	-0.774	-0.405	-1.358	-0.774	-1.358	-0.281	-0.567	-0.567	0.452	2.116	4.521
CHEBOTAEV_GR_TARGETS_DN CHEBOTAEV_GR_TARGETS_DN	0.578	-0.566	-2.101	-1.299	-0.292	-0.412	-1.299	-0.566	0.945	0.945	4.204
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	0.499	-0.438	-0.438	-0.438	-0.986	-2.945	-0.276	-0.668	3.280	1.592	0.330
GENTILE_RESPONSE_CLUSTER_D3 GENTILE_RESPONSE_CLUSTER_D3	-1.397	0.980	0.272	1.319	0.272	-2.197	0.980	1.706	-0.893	-1.397	-0.330
ELVIDGE_HYPOXIA_BY_DMOG_UP ELVIDGE_HYPOXIA_BY_DMOG_UP	0.264	-0.849	1.271	-1.416	-1.416	-2.247	-0.641	0.504	0.372	2.750	1.533
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	-2.322	1.551	0.877	0.612	0.233	-1.501	1.957	-0.382	-0.382	0.233	-1.496
KIM_WT1_TARGETS_8HR_UP KIM_WT1_TARGETS_8HR_UP	-1.901	-0.261	1.306	-0.475	-0.475	-3.323	0.907	0.457	-0.475	-0.261	2.968
MIKKELSEN_ES_LCP_WITH_H3K4ME3 MIKKELSEN_ES_LCP_WITH_H3K4ME3	2.578	-1.362	-1.074	-1.706	0.257	-0.638	0.257	-0.638	-0.638	0.795	3.290
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP	0.283	-1.243	-0.320	-1.243	-1.243	0.283	-1.243	0.539	1.301	1.301	1.306
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	-0.810	-0.329	0.651	1.928	-0.527	-2.654	1.928	0.906	0.274	-1.211	-0.806
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	-0.241	-0.241	-1.077	1.088	-1.077	-1.077	-1.077	-0.520	1.088	0.684	2.154
KASLER_HDAC7_TARGETS_1_UP KASLER_HDAC7_TARGETS_1_UP	-0.978	0.425	1.185	1.847	-0.978	-4.103	0.325	1.847	0.325	-0.621	-0.366
BROWN_MYELOID_CELL_DEVELOPMENT_UP BROWN_MYELOID_CELL_DEVELOPMENT_UP	-0.475	-0.621	-0.798	0.457	-1.901	-1.261	1.097	-0.475	0.457	5.218	-0.470
ZHU_CMV_ALL_DN ZHU_CMV_ALL_DN	-0.322	0.914	-0.322	-0.848	-0.629	-1.872	-2.382	-0.456	0.914	0.914	3.408
BROWNE_HCMV_INFECTION_2HR_UP BROWNE_HCMV_INFECTION_2HR_UP	0.527	-0.958	-0.549	-0.958	-0.958	-0.958	0.527	-0.300	-0.958	3.813	1.600
FOSTER_KDM1A_TARGETS_DN FOSTER_KDM1A_TARGETS_DN	-0.264	0.341	2.932	1.009	-0.586	-3.236	0.442	0.842	0.559	-0.919	-1.962
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	-1.907	1.677	-0.411	1.677	-0.702	-0.702	-0.228	0.920	1.271	-1.158	-1.153
DANG_REGULATED_BY_MYC_UP DANG_REGULATED_BY_MYC_UP	0.560	2.546	0.790	-0.240	-0.240	-2.820	1.062	-0.240	-0.390	-1.332	-1.326
XU_RESPONSE_TO_TRETINOIN_UP XU_RESPONSE_TO_TRETINOIN_UP	-0.663	-0.663	-0.663	0.362	-0.663	-0.247	2.696	0.362	-0.663	1.939	-0.661
ENGELMANN_CANCER_PROGENITORS_UP ENGELMANN_CANCER_PROGENITORS_UP	-0.451	-0.256	0.571	-0.451	-1.990	-1.990	-0.755	-0.256	0.848	1.565	2.009
GAJATE_RESPONSE_TO_TRABECTEDIN_UP GAJATE_RESPONSE_TO_TRABECTEDIN_UP	0.405	-0.566	-0.566	-0.860	-0.566	-2.737	-0.566	0.250	0.846	3.664	0.851
KIM_WT1_TARGETS_12HR_UP KIM_WT1_TARGETS_12HR_UP	-0.261	-0.798	-0.621	-0.798	-1.010	-3.323	0.345	1.097	0.587	0.907	3.306
AFFAR_YY1_TARGETS_UP AFFAR_YY1_TARGETS_UP	0.583	-1.095	-1.612	-1.095	-0.437	-0.334	-1.095	-1.095	1.660	1.660	3.025
XU_AKT1_TARGETS_6HR XU_AKT1_TARGETS_6HR	0.644	1.503	1.032	-0.260	-1.119	-1.119	1.503	0.347	-1.119	-0.550	-1.116
WHITFIELD_CELL_CYCLE_LITERATURE WHITFIELD_CELL_CYCLE_LITERATURE	-1.090	0.684	0.998	0.998	-0.373	-1.090	2.807	0.239	-0.373	-1.824	-1.086
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	0.937	-1.253	-1.739	-1.253	0.339	0.701	-0.888	-0.412	-0.888	1.856	2.647
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	-0.782	-0.271	1.512	0.334	-0.782	-2.031	0.814	1.512	0.814	-0.271	-2.026
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	-0.652	0.612	-1.093	-0.360	-0.360	0.612	-1.384	-2.637	0.777	0.469	4.008
LAU_APOPTOSIS_CDKN2A_UP LAU_APOPTOSIS_CDKN2A_UP	-0.949	0.416	0.910	0.245	-1.466	-2.280	1.601	0.637	1.232	0.416	-1.461
MEBARKI_HCC_PROGENITOR_WNT_DN MEBARKI_HCC_PROGENITOR_WNT_DN	0.336	0.889	-3.818	-0.589	0.336	-0.833	-1.151	0.336	1.419	1.731	0.340
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	-1.124	-0.676	0.654	-1.124	-0.676	-1.124	-0.676	-0.392	0.958	0.958	3.910
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	0.536	-0.580	-0.311	0.291	-2.007	-3.761	-0.580	0.872	1.298	1.545	0.879
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	-1.294	-0.492	-0.810	0.781	-0.492	-2.073	1.877	1.461	-0.285	1.461	-0.806
NAGASHIMA_NRG1_SIGNALING_UP NAGASHIMA_NRG1_SIGNALING_UP	-0.415	-0.545	0.509	-1.118	-1.382	-2.952	1.381	0.976	-0.704	2.412	0.985
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	1.320	-1.124	-1.124	-0.392	-0.676	-0.392	-1.865	0.226	0.226	1.320	2.732
MORI_PRE_BI_LYMPHOCYTE_DN MORI_PRE_BI_LYMPHOCYTE_DN	-0.820	-0.820	-0.559	-2.290	-1.171	-0.559	0.772	1.997	2.813	0.381	0.384
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	-0.313	-0.473	-1.868	-0.691	-0.313	0.289	-1.364	-0.981	0.435	2.415	3.281
MIKKELSEN_MEF_LCP_WITH_H3K27ME3 MIKKELSEN_MEF_LCP_WITH_H3K27ME3	0.966	0.712	-2.035	-0.668	2.366	0.966	-1.424	-1.424	-0.986	0.499	0.503
GAJATE_RESPONSE_TO_TRABECTEDIN_DN GAJATE_RESPONSE_TO_TRABECTEDIN_DN	0.566	4.558	0.256	0.256	-0.351	-0.828	-0.828	-0.351	0.256	-0.828	-0.826
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	-0.388	0.610	2.368	-0.538	-1.609	-1.254	-1.254	2.713	0.990	-0.963	-0.533
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	-0.782	0.334	1.938	1.137	-1.259	-1.259	1.512	0.546	-0.472	-0.271	-2.026
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	-0.672	2.081	1.112	2.081	-0.958	-2.510	0.636	-0.672	-0.672	0.301	-0.952
SANA_RESPONSE_TO_IFNG_UP SANA_RESPONSE_TO_IFNG_UP	0.642	3.071	-0.314	0.642	-2.144	-1.517	-1.517	-0.488	0.288	1.153	-0.311
HEDENFALK_BREAST_CANCER_BRACX_DN HEDENFALK_BREAST_CANCER_BRACX_DN	-0.828	2.148	-0.828	0.256	0.991	-0.828	1.521	-0.828	0.256	-0.828	-0.350
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	-0.817	0.265	2.298	-0.465	-1.682	-3.159	-0.465	1.718	0.814	0.643	0.268
GAVIN_FOXP3_TARGETS_CLUSTER_P3 GAVIN_FOXP3_TARGETS_CLUSTER_P3	0.770	-0.594	-1.221	-0.594	-1.512	-2.715	0.480	0.615	0.268	2.401	1.853
WIERENGA_STAT5A_TARGETS_GROUP1 WIERENGA_STAT5A_TARGETS_GROUP1	1.410	0.945	-0.292	-1.299	-0.761	-4.136	-0.761	0.432	0.749	0.749	0.952
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1 RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	-1.782	-0.624	2.353	-0.624	0.254	-1.057	1.040	0.715	1.423	-0.624	-1.053
KOBAYASHI_EGFR_SIGNALING_24HR_UP KOBAYASHI_EGFR_SIGNALING_24HR_UP	-1.407	-0.553	-1.407	-0.771	0.346	-1.858	-0.385	0.667	2.709	1.986	0.672
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	-0.364	-0.771	-1.477	-0.364	-0.538	0.736	-0.538	-0.771	-0.771	5.504	0.742
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2 BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	-1.393	0.997	0.997	2.425	-0.647	-1.393	1.297	0.519	-0.961	-0.647	-1.387
GAVIN_FOXP3_TARGETS_CLUSTER_P6 GAVIN_FOXP3_TARGETS_CLUSTER_P6	-1.127	0.504	3.334	1.772	-0.812	-1.127	0.693	0.504	-1.127	-1.127	-0.807
FINETTI_BREAST_CANCERS_KINOME_GRAY FINETTI_BREAST_CANCERS_KINOME_GRAY	-0.621	-0.223	0.396	0.823	-0.621	-0.621	0.396	3.770	-0.621	-0.621	-0.620
BILANGES_SERUM_SENSITIVE_VIA_TSC2 BILANGES_SERUM_SENSITIVE_VIA_TSC2	0.836	-0.341	0.264	0.836	0.264	-1.284	2.878	-0.671	-1.284	-1.284	0.266
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	0.946	-1.768	-1.329	0.259	-0.348	-1.768	-0.506	0.259	-0.348	3.282	1.481
KOBAYASHI_EGFR_SIGNALING_6HR_DN KOBAYASHI_EGFR_SIGNALING_6HR_DN	-0.298	0.304	-0.746	-0.746	-0.746	-0.746	-0.298	-0.746	0.655	1.128	3.190
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	-0.746	-0.746	-0.746	-0.298	-0.746	-0.746	0.304	-0.298	3.182	0.655	1.132
PLASARI_TGFB1_TARGETS_10HR_UP PLASARI_TGFB1_TARGETS_10HR_UP	1.104	-0.310	-0.528	-2.217	-0.844	-1.045	-0.844	-1.045	0.926	2.521	1.998
NAKAMURA_ADIPOGENESIS_EARLY_DN NAKAMURA_ADIPOGENESIS_EARLY_DN	-0.430	-0.219	-0.796	-1.450	-0.796	-0.219	-0.796	-0.430	1.030	4.453	0.405
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	0.530	1.700	1.964	1.025	0.301	-1.755	-0.301	-0.409	0.301	-3.133	-1.135
JIANG_HYPOXIA_CANCER JIANG_HYPOXIA_CANCER	-0.668	1.112	0.362	0.564	-2.405	-1.035	2.275	-0.247	-0.247	0.814	-1.566
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	-0.341	-0.671	-1.284	0.509	0.264	-1.284	0.836	1.241	-0.341	-1.284	2.273
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	-0.580	0.892	-0.580	-0.199	-0.199	-0.580	-0.580	-0.580	0.434	-0.580	4.015
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	-0.458	-0.739	0.692	1.843	-4.403	-1.130	1.393	0.442	0.842	-0.264	-0.347
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	0.243	2.813	-0.369	0.558	-1.171	-3.236	1.313	-0.369	-0.559	0.243	0.245
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	-0.981	0.615	1.082	1.684	-1.364	-2.547	-0.313	2.034	0.289	-0.313	-0.976
RASHI_RESPONSE_TO_IONIZING_RADIATION_2 RASHI_RESPONSE_TO_IONIZING_RADIATION_2	-0.388	0.610	0.610	-0.727	-3.227	-0.963	0.610	-0.963	3.080	0.990	-0.384
YU_MYC_TARGETS_UP YU_MYC_TARGETS_UP	-1.057	1.423	1.423	0.715	-0.624	-1.782	1.861	0.254	-0.624	-1.057	-0.621
ALONSO_METASTASIS_EMT_UP ALONSO_METASTASIS_EMT_UP	-1.450	-0.430	-0.430	-0.796	-0.796	-0.796	-0.796	1.030	1.030	0.680	3.090
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	0.759	-0.751	-1.966	-0.751	-0.751	-0.522	0.256	-1.448	0.759	1.899	2.668
DELPUECH_FOXO3_TARGETS_UP DELPUECH_FOXO3_TARGETS_UP	-0.344	-0.835	-0.344	-1.819	-0.344	-1.819	0.422	-0.546	0.627	1.502	3.238
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN	0.283	0.283	-1.243	-1.243	-1.243	-1.243	0.539	0.539	0.880	0.539	1.802
ZHAN_MULTIPLE_MYELOMA_CD1_DN ZHAN_MULTIPLE_MYELOMA_CD1_DN	0.370	-1.191	-0.729	1.225	-1.948	-1.948	0.883	0.370	0.883	0.370	0.887
BURTON_ADIPOGENESIS_10 BURTON_ADIPOGENESIS_10	-0.341	0.264	0.836	0.509	-1.284	-0.671	0.509	2.878	-1.284	-1.284	0.266
MARSON_FOXP3_TARGETS_UP MARSON_FOXP3_TARGETS_UP	-1.302	-0.885	0.818	0.388	-1.302	-0.885	0.388	1.776	1.776	0.818	-1.884
HUANG_DASATINIB_SENSITIVITY_UP HUANG_DASATINIB_SENSITIVITY_UP	-0.397	-0.397	-0.397	-1.225	-1.707	-2.363	-0.255	1.555	1.555	1.243	0.971
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	0.822	-0.722	-1.162	-0.722	-1.446	-1.162	0.660	-0.923	0.292	1.671	3.533
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	-0.538	-0.538	2.370	-0.538	-0.176	-0.538	0.967	-0.538	1.603	-0.538	-0.537
SUNG_METASTASIS_STROMA_UP SUNG_METASTASIS_STROMA_UP	-0.668	0.721	-0.479	-0.334	-1.214	-3.447	-0.479	0.721	1.715	2.031	0.273
MIKKELSEN_MEF_LCP_WITH_H3K4ME3 MIKKELSEN_MEF_LCP_WITH_H3K4ME3	0.563	-0.424	-0.581	-1.023	-1.687	-2.130	0.731	-0.778	0.731	1.935	2.259
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	-0.500	-0.500	-0.893	-0.893	-0.500	4.054	-0.893	-0.500	-0.266	-0.266	2.230
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	-0.541	-0.292	-0.541	0.310	-2.759	-2.759	0.310	1.300	1.300	0.884	1.309
SERVITJA_LIVER_HNF1A_TARGETS_DN SERVITJA_LIVER_HNF1A_TARGETS_DN	1.140	0.364	-0.975	-1.852	-0.767	2.401	-1.512	-0.337	-1.221	1.140	1.365
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	0.607	-0.580	-0.580	-1.160	-0.280	-1.160	-0.280	-1.160	1.432	0.978	1.968
SENESE_HDAC2_TARGETS_UP SENESE_HDAC2_TARGETS_UP	-3.714	-0.582	0.775	1.765	-0.291	-1.055	1.765	-0.418	0.775	-0.582	-0.288
TOOKER_GEMCITABINE_RESISTANCE_DN TOOKER_GEMCITABINE_RESISTANCE_DN	0.353	0.486	1.531	0.353	-1.209	-3.982	0.486	1.531	0.644	-0.924	-0.505
WARTERS_IR_RESPONSE_5GY WARTERS_IR_RESPONSE_5GY	-0.271	-1.259	-2.031	-0.472	-0.271	-1.259	-0.271	0.814	2.929	0.814	0.549
SCIBETTA_KDM5B_TARGETS_DN SCIBETTA_KDM5B_TARGETS_DN	-1.198	0.367	0.748	1.949	-0.577	-2.326	1.596	0.538	0.538	-1.675	-0.573
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	-1.408	-1.077	-0.598	0.959	-1.408	-1.815	0.426	-0.301	2.037	0.959	1.740
BAKKER_FOXO3_TARGETS_DN BAKKER_FOXO3_TARGETS_DN	-0.718	0.785	3.326	2.378	-0.718	-1.403	-0.558	-0.319	-0.909	-1.403	0.288
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	1.984	-0.512	-0.512	-1.487	-2.896	-0.512	-0.512	-0.265	0.611	0.782	2.304
KATSANOU_ELAVL1_TARGETS_UP KATSANOU_ELAVL1_TARGETS_UP	0.646	-1.118	-1.118	-0.893	-1.691	-0.310	-0.704	0.292	0.392	1.381	4.111
LUCAS_HNF4A_TARGETS_UP LUCAS_HNF4A_TARGETS_UP	-0.416	-1.571	-0.416	-0.416	-1.035	-1.571	1.456	1.844	-0.416	2.275	-0.245
NADLER_OBESITY_UP NADLER_OBESITY_UP	-1.093	-1.642	-0.715	-0.274	-0.274	-1.093	-0.452	1.039	2.607	2.153	-0.449
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	-1.024	0.749	0.476	-0.336	-1.024	-0.599	-0.336	4.939	0.269	-0.599	-1.020
MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD	-0.264	0.737	-2.903	-0.647	-0.264	-1.393	-0.647	0.737	1.636	1.636	-0.261
WANG_RECURRENT_LIVER_CANCER_UP WANG_RECURRENT_LIVER_CANCER_UP	-0.828	-0.828	0.566	1.521	0.256	-0.828	1.521	0.991	-0.828	-0.828	-0.350
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	-0.869	0.419	1.491	-0.634	-0.634	-3.372	0.762	-0.451	-0.634	0.762	2.125
COATES_MACROPHAGE_M1_VS_M2_UP COATES_MACROPHAGE_M1_VS_M2_UP	-0.326	0.419	0.806	0.419	-1.005	-3.568	-0.489	-0.489	0.278	2.768	0.423
LIU_COMMON_CANCER_GENES LIU_COMMON_CANCER_GENES	-1.211	-0.810	1.205	0.274	-0.329	-2.654	0.906	1.205	1.546	-0.810	-0.327
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	-1.362	0.257	-0.350	0.257	-2.117	-1.074	-0.350	-0.834	1.197	2.261	2.274
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY	0.302	0.302	0.527	-1.658	1.176	1.176	-0.300	-1.658	-1.658	0.820	0.304
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP	0.285	2.514	-1.699	-0.574	-1.699	0.285	0.501	1.129	0.285	-0.991	0.287
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	-2.621	-0.338	0.267	0.576	-1.029	-1.029	-0.731	3.596	0.576	0.404	0.580
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	0.267	-0.505	-1.029	-0.731	0.404	3.140	-1.420	-1.029	-1.029	0.782	1.953
ZHANG_PROLIFERATING_VS_QUIESCENT ZHANG_PROLIFERATING_VS_QUIESCENT	-1.259	-0.782	1.512	-0.472	-0.782	-2.031	1.512	0.546	1.512	0.334	-0.469
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	-1.144	0.578	1.055	1.680	-0.355	-2.253	0.396	1.680	0.253	-0.797	-1.605
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	0.716	1.960	1.387	-1.457	-1.872	-2.382	-0.456	0.914	-0.322	0.281	0.404
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP FIGUEROA_AML_METHYLATION_CLUSTER_7_UP	-0.443	1.998	0.291	0.291	-0.829	-1.099	-1.099	3.447	-1.099	-1.099	0.741
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	0.468	1.074	0.736	-2.021	-1.681	-0.914	-0.335	-1.132	-0.572	1.714	2.242
LIU_SOX4_TARGETS_UP LIU_SOX4_TARGETS_UP	-0.751	-0.751	0.414	-0.418	-1.583	-0.751	0.892	2.789	1.846	0.414	-1.970
SCHEIDEREIT_IKK_INTERACTING_PROTEINS SCHEIDEREIT_IKK_INTERACTING_PROTEINS	0.272	-0.556	-0.556	-0.332	-0.556	-1.397	0.980	1.706	2.139	0.272	-2.191
VERHAAK_GLIOBLASTOMA_NEURAL VERHAAK_GLIOBLASTOMA_NEURAL	-1.299	-1.299	0.311	-1.003	-1.003	-1.299	0.749	2.286	2.286	-0.292	0.755
JACKSON_DNMT1_TARGETS_UP JACKSON_DNMT1_TARGETS_UP	-1.771	0.484	0.909	0.909	-0.911	-3.402	0.484	0.326	0.909	-0.278	0.683
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	0.852	-0.442	-0.442	-0.442	-2.515	-3.093	1.272	1.051	0.852	0.283	0.859
WANG_HCP_PROSTATE_CANCER WANG_HCP_PROSTATE_CANCER	1.002	-0.617	-0.438	-0.438	-1.979	-2.568	-0.301	0.593	1.524	2.156	-0.298
GRABARCZYK_BCL11B_TARGETS_UP GRABARCZYK_BCL11B_TARGETS_UP	-1.253	0.502	0.339	0.339	-1.739	-2.400	0.701	2.635	0.937	-0.266	-0.409
ZAMORA_NOS2_TARGETS_UP ZAMORA_NOS2_TARGETS_UP	-0.977	1.957	1.190	0.612	-0.977	-0.382	0.233	1.957	-0.977	-1.501	-0.973
ISSAEVA_MLL2_TARGETS ISSAEVA_MLL2_TARGETS	0.498	1.004	-0.738	-0.738	-0.470	-0.470	-2.529	-0.738	-0.287	1.689	2.103
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	-0.366	-0.255	-0.694	-2.509	-0.366	-1.985	1.531	1.815	0.486	-0.510	1.541
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	-0.253	2.241	-0.253	-1.285	-1.676	-1.285	-0.720	2.241	-0.369	-0.522	1.342
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2 SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	-1.010	0.738	-1.010	1.097	-1.556	-2.304	-0.475	0.907	1.534	1.781	-0.470
KYNG_DNA_DAMAGE_DN KYNG_DNA_DAMAGE_DN	-1.877	-0.502	-0.285	2.145	-0.285	-2.255	1.408	1.198	1.006	-0.821	-0.814
MOSERLE_IFNA_RESPONSE MOSERLE_IFNA_RESPONSE	0.793	2.771	0.480	-0.702	-1.326	-1.326	1.184	-0.363	-0.702	-0.363	-0.361
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	0.434	2.211	2.211	-0.580	-0.580	-0.580	-0.199	-0.199	-0.580	-0.580	-0.578
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	0.892	-0.873	-0.699	0.473	-3.148	-1.591	-0.551	0.473	1.256	1.065	1.699
BROWNE_HCMV_INFECTION_24HR_UP BROWNE_HCMV_INFECTION_24HR_UP	-0.371	-0.503	1.377	0.338	-2.667	-2.172	2.828	-0.267	-0.267	0.597	-0.263
WEI_MIR34A_TARGETS WEI_MIR34A_TARGETS	-1.113	0.759	1.897	0.597	-0.667	-3.259	1.377	0.759	0.338	-1.113	-0.498
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	1.656	-0.925	-0.925	-1.616	0.858	0.555	-0.925	0.555	-0.925	-0.283	1.662
VANTVEER_BREAST_CANCER_BRCA1_DN VANTVEER_BREAST_CANCER_BRCA1_DN	-1.616	-0.525	-0.525	-0.925	-0.283	-0.925	1.226	-0.283	-0.283	3.284	0.862
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	-0.381	-0.537	0.344	2.547	-0.381	-2.194	1.303	1.576	-0.381	-0.738	-1.696
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	-1.160	-0.580	0.607	-0.580	-1.160	-1.160	0.607	-0.280	0.607	2.564	0.609
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	-0.893	1.319	0.455	0.691	0.455	-2.197	1.319	0.980	-0.893	-0.556	-1.392
KRIGE_AMINO_ACID_DEPRIVATION KRIGE_AMINO_ACID_DEPRIVATION	4.599	0.572	0.302	-0.610	-0.610	-1.202	-0.610	-0.610	0.572	-0.300	-0.608
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	-0.733	2.092	2.669	0.453	-0.385	-1.367	0.453	-0.733	-0.733	-0.385	-0.730
ROESSLER_LIVER_CANCER_METASTASIS_UP ROESSLER_LIVER_CANCER_METASTASIS_UP	-1.143	0.783	4.179	-0.617	-0.617	-1.143	-0.438	1.249	0.432	-0.617	-1.137
BAELDE_DIABETIC_NEPHROPATHY_UP BAELDE_DIABETIC_NEPHROPATHY_UP	-0.247	0.714	-1.102	-0.377	-1.505	-0.377	-1.102	-0.247	-0.792	0.940	4.372
BHATTACHARYA_EMBRYONIC_STEM_CELL BHATTACHARYA_EMBRYONIC_STEM_CELL	-0.672	0.856	2.081	2.081	0.301	-1.836	0.636	-0.301	-1.336	-0.958	-0.952
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	-1.064	-1.606	1.075	0.784	-0.691	-2.446	1.075	1.075	0.541	0.346	-0.258
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	0.250	0.846	1.825	0.846	0.250	-1.855	1.132	0.405	-0.860	-1.855	-1.266
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	-1.819	-0.546	0.422	1.876	-0.835	-1.241	2.289	0.422	0.627	0.262	-1.236
QI_HYPOXIA QI_HYPOXIA	-0.342	0.504	1.522	-1.104	-2.798	-2.247	-0.342	1.044	0.660	0.660	0.847
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	0.301	-0.301	1.402	1.726	-1.336	-2.510	-0.672	1.726	-0.301	-0.958	0.304
YAMAZAKI_TCEB3_TARGETS_UP YAMAZAKI_TCEB3_TARGETS_UP	0.355	0.601	0.601	-0.782	-1.877	-2.745	0.754	1.118	2.365	-0.347	-0.776
OHGUCHI_LIVER_HNF4A_TARGETS_DN OHGUCHI_LIVER_HNF4A_TARGETS_DN	1.752	0.336	-2.331	-1.578	-0.486	2.594	-0.813	-0.634	-0.486	0.722	0.729
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	0.946	-3.070	-0.714	-0.984	0.728	0.946	-0.506	-0.714	-0.348	0.384	2.490
FRASOR_RESPONSE_TO_ESTRADIOL_DN FRASOR_RESPONSE_TO_ESTRADIOL_DN	0.243	0.243	-0.369	-0.369	-0.820	-1.643	-0.820	-0.559	0.558	0.243	5.404
NAKAYAMA_FRA2_TARGETS NAKAYAMA_FRA2_TARGETS	-1.948	-0.729	0.370	-0.242	-0.431	-1.948	-0.242	0.370	0.883	2.066	0.887
ONDER_CDH1_SIGNALING_VIA_CTNNB1 ONDER_CDH1_SIGNALING_VIA_CTNNB1	-0.458	-0.301	-0.458	-1.836	-1.836	0.301	-0.458	-0.458	0.451	2.081	2.898
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	-0.255	-1.225	0.353	-2.363	-0.255	-1.225	-0.397	-0.397	0.724	1.902	2.292
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	-0.352	0.643	-1.439	-1.819	-0.656	-1.819	0.820	0.361	0.255	2.706	1.254
HECKER_IFNB1_TARGETS HECKER_IFNB1_TARGETS	0.472	2.395	1.109	-0.606	-2.131	-0.418	0.324	-2.131	-0.854	0.472	0.870
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11 GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	-0.508	-0.508	-0.315	1.593	-0.315	-2.613	0.675	2.411	-0.315	0.288	-1.176
EINAV_INTERFERON_SIGNATURE_IN_CANCER EINAV_INTERFERON_SIGNATURE_IN_CANCER	-0.260	2.052	1.032	0.644	-0.550	-1.119	1.032	-0.260	-1.119	-1.119	-0.548
SEKI_INFLAMMATORY_RESPONSE_LPS_DN SEKI_INFLAMMATORY_RESPONSE_LPS_DN	-0.406	0.873	-0.406	-0.911	-0.911	-0.911	-0.911	0.490	0.217	1.356	1.938
BRUINS_UVC_RESPONSE_MIDDLE BRUINS_UVC_RESPONSE_MIDDLE	-1.303	0.398	1.224	-0.491	0.269	-0.696	0.269	1.507	1.819	-0.491	-3.022
ANDERSEN_LIVER_CANCER_KRT19_UP ANDERSEN_LIVER_CANCER_KRT19_UP	-1.409	0.216	0.427	1.079	-1.409	-0.765	2.571	0.716	-0.407	0.216	-0.762
BURTON_ADIPOGENESIS_12 BURTON_ADIPOGENESIS_12	-0.702	-1.326	3.426	0.793	-0.702	-1.326	0.480	0.247	0.247	-0.363	0.248
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	0.439	0.328	-0.856	0.328	-2.065	-3.039	-0.276	0.328	0.723	1.789	1.547
MARTIN_VIRAL_GPCR_SIGNALING_UP MARTIN_VIRAL_GPCR_SIGNALING_UP	0.267	1.297	-1.420	-1.029	-1.029	0.576	0.267	-2.621	1.297	0.782	1.030
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	-0.392	0.958	-0.392	-1.124	-1.124	1.320	-1.865	0.226	-0.676	1.320	1.325
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	-1.431	-0.578	0.944	-0.578	-0.578	-0.578	2.543	0.664	1.652	-0.578	-1.426
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2 PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	0.620	-0.327	0.276	-0.506	-3.111	-1.091	-0.753	0.276	0.620	1.426	1.778
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1 PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	0.920	-0.228	-0.411	-1.158	-1.907	-0.702	-0.411	-0.411	-0.228	0.920	3.204
WESTON_VEGFA_TARGETS WESTON_VEGFA_TARGETS	-0.875	-0.624	-0.432	-0.624	-0.432	-0.290	0.840	-2.882	1.351	0.456	2.747
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	1.788	-0.250	-1.533	-0.860	-0.477	0.359	-0.477	-0.860	-0.860	1.332	1.795
PEART_HDAC_PROLIFERATION_CLUSTER_UP PEART_HDAC_PROLIFERATION_CLUSTER_UP	-2.197	-0.332	-0.332	3.135	-0.332	-1.397	0.455	0.980	-0.332	0.455	-0.553
SUNG_METASTASIS_STROMA_DN SUNG_METASTASIS_STROMA_DN	-0.921	0.435	1.652	1.274	0.664	-2.239	-0.578	-0.578	0.435	-1.431	0.668
TONG_INTERACT_WITH_PTTG1 TONG_INTERACT_WITH_PTTG1	-0.645	-0.645	0.845	0.587	-0.399	-2.363	1.503	1.151	0.845	-0.399	-1.531
LIN_MELANOMA_COPY_NUMBER_DN LIN_MELANOMA_COPY_NUMBER_DN	-0.574	0.285	0.783	0.783	-1.699	-1.699	1.534	0.285	1.129	-0.991	-0.316
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	-0.645	-0.645	0.379	-0.645	-0.645	-2.363	1.503	0.587	2.339	-0.645	0.591
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	1.856	-0.266	-0.888	-0.614	-1.739	-1.739	0.937	0.937	-0.888	0.339	1.524
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	2.797	-0.363	-0.479	-2.203	-0.993	0.706	-1.230	-0.479	-0.479	1.941	0.570
LIU_VMYB_TARGETS_UP LIU_VMYB_TARGETS_UP	-1.254	0.990	-0.388	-0.273	-0.963	-2.573	0.990	0.788	2.713	-0.538	-0.384
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	1.057	-0.787	-0.787	-0.787	0.279	0.609	-0.787	-0.787	-0.324	1.613	1.060
SABATES_COLORECTAL_ADENOMA_UP SABATES_COLORECTAL_ADENOMA_UP	1.298	-0.580	-1.274	-0.430	0.536	0.536	-3.060	0.291	-0.996	1.074	1.825
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	3.596	-0.338	-1.029	-0.731	-1.029	-0.338	-1.420	-0.338	0.404	-0.338	1.953
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	1.939	1.939	-0.663	-0.247	-0.663	-0.663	-0.247	-0.663	0.762	-0.247	-0.661
VALK_AML_WITH_EVI1 VALK_AML_WITH_EVI1	1.149	-0.222	-0.491	-1.036	-1.036	-1.036	-0.491	-0.222	1.149	2.249	-0.221
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1 KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	-0.520	2.792	-0.241	0.684	-1.077	0.371	-1.077	0.684	0.371	-1.077	-0.518
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	0.872	-1.407	-0.771	0.667	-2.432	-1.407	-0.260	0.492	0.492	0.872	1.997
CORRE_MULTIPLE_MYELOMA_DN CORRE_MULTIPLE_MYELOMA_DN	0.814	-0.416	-1.035	-0.416	-0.668	-1.571	-0.416	-0.668	1.112	-0.247	3.819
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	-0.276	-2.035	-0.276	0.328	-1.424	-2.035	1.259	0.328	0.712	1.259	0.972
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	-0.581	0.388	0.659	-0.759	-0.975	-4.194	1.457	0.659	1.016	0.388	0.518
RODWELL_AGING_KIDNEY_NO_BLOOD_DN RODWELL_AGING_KIDNEY_NO_BLOOD_DN	-0.541	-0.402	1.539	0.554	-0.712	-3.359	0.884	0.310	1.300	-1.474	0.714
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	-0.442	-0.289	0.883	-0.652	-0.934	-3.444	0.883	1.439	0.883	-0.442	0.471
YANG_BREAST_CANCER_ESR1_BULK_DN YANG_BREAST_CANCER_ESR1_BULK_DN	-0.911	-0.911	0.873	1.932	0.217	-0.911	-0.911	-0.406	0.217	1.356	0.218
SEIDEN_MET_SIGNALING SEIDEN_MET_SIGNALING	-0.828	0.566	0.991	-0.828	1.521	-0.828	0.991	0.256	-0.828	-0.828	0.257
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP	2.160	0.301	0.402	-1.362	-0.877	-1.362	0.522	-0.533	0.301	-1.362	2.770
ODONNELL_METASTASIS_UP ODONNELL_METASTASIS_UP	2.444	1.055	-0.541	0.253	0.253	-0.797	-3.194	0.253	-0.541	0.578	0.256
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	1.254	-2.570	-1.403	-0.889	-0.693	0.309	-0.399	-0.399	1.254	1.729	1.055
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	1.846	-0.566	-0.301	-1.583	0.710	1.846	-0.301	-2.455	-0.977	0.301	0.716
LIU_CMYB_TARGETS_UP LIU_CMYB_TARGETS_UP	-1.490	-0.441	0.374	0.276	-1.490	-1.490	-0.328	0.787	3.784	0.787	-0.324
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	-0.893	0.509	-0.310	2.412	-1.118	-2.468	1.169	1.381	-0.893	0.292	-0.411
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP	1.052	-0.497	0.166	-0.497	-0.497	3.495	-0.497	-0.497	-0.497	0.166	0.167
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	0.312	-0.875	-0.624	-0.875	-0.875	-0.875	-0.875	0.312	0.312	3.593	1.995
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	-1.261	-0.357	0.882	1.363	-0.703	-1.261	1.951	0.882	0.511	-0.508	-2.123
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	0.816	-1.334	-1.334	-0.552	-0.272	1.032	-0.393	-1.334	-0.393	0.333	3.692
MANN_RESPONSE_TO_AMIFOSTINE_UP MANN_RESPONSE_TO_AMIFOSTINE_UP	-0.787	0.279	-0.787	-0.324	0.279	-0.787	-0.324	1.057	3.018	-0.787	0.280
TAKAO_RESPONSE_TO_UVB_RADIATION_UP TAKAO_RESPONSE_TO_UVB_RADIATION_UP	-1.029	-0.731	0.404	1.297	0.267	-1.420	1.023	1.297	0.782	0.267	-2.612
WOOD_EBV_EBNA1_TARGETS_UP WOOD_EBV_EBNA1_TARGETS_UP	-0.930	0.905	0.380	0.905	-1.237	-3.485	0.526	-0.346	0.701	1.394	-0.342
CAIRO_LIVER_DEVELOPMENT_UP CAIRO_LIVER_DEVELOPMENT_UP	0.260	0.601	1.118	-0.347	-2.277	-2.277	0.601	-0.464	-0.347	-0.347	2.686
AGARWAL_AKT_PATHWAY_TARGETS AGARWAL_AKT_PATHWAY_TARGETS	-0.456	-0.456	0.187	-0.456	-0.456	-0.456	-0.456	-0.456	2.747	0.578	1.150
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	1.126	-0.436	-0.732	-1.737	-0.570	-0.926	-0.570	-0.732	0.276	2.953	1.816
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	-1.254	0.788	0.331	-1.254	-0.538	-2.573	0.331	-0.388	1.218	1.746	0.998
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN	-0.456	1.875	-0.456	0.578	-0.456	0.187	-0.456	1.875	-0.456	-0.456	-0.454
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN	1.256	-0.414	-0.414	0.211	-0.414	-0.414	-0.414	-0.414	-0.414	0.211	2.982
ONGUSAHA_BRCA1_TARGETS_UP ONGUSAHA_BRCA1_TARGETS_UP	1.603	-0.538	-0.538	-0.176	-0.176	-0.538	-0.538	-0.538	-0.538	0.967	1.606
IIZUKA_LIVER_CANCER_EARLY_RECURRENCE IIZUKA_LIVER_CANCER_EARLY_RECURRENCE	-0.456	0.187	-0.456	-0.456	-0.456	-0.456	1.875	1.148	1.148	-0.456	-0.454
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP	-0.414	-0.414	2.039	0.211	-0.414	-0.414	2.039	0.211	-0.414	-0.414	-0.413
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN CAIRO_PML_TARGETS_BOUND_BY_MYC_DN	0.476	-0.538	-0.538	-0.176	-0.538	-0.538	0.476	-0.538	0.967	-0.538	2.375
